Criteria, scores and classifications come first: one table per set from the slides (Wells, Virchow, Rutherford, ankle-brachial index, CHA2DS2-VASc, HAS-BLED, the Duke criteria and more), each with a labeled memory aid. Then venous disorders, arterial occlusive disease and aortic aneurysm, and cardiomyopathy, condensed from the Exam 5 study guide: the Virchow triad and Wells criteria first, then deep vein thrombosis, chronic venous insufficiency, claudication and the ankle-brachial index, acute limb ischemia, carotid and aneurysm thresholds, dissection, and the five cardiomyopathies. Lectures 26 and 28 carry the lecturers’ emphasis (starred; Lecture 28 gives recording times in parentheses); Lecture 27 is built from the slides only, with its audio emphasis to be added after 10/01. Lectures 29–32 add the supraventricular and ventricular arrhythmias and blocks, pericardial disease and infective endocarditis (slides, with each lecturer's recording emphasis starred).
| Type | Cause (slide 10) |
|---|---|
| Primary | Intrinsic structural or functional abnormality of the vein wall or the venous valves, leading to valvular reflux |
| Secondary | Obstruction and/or valvular incompetence from a prior deep vein thrombosis |
Primary = the Pipe itself; Secondary = Sequel of a clot.
P Pipe: vein wall or valve abnormalityS Sequel: a prior deep vein thrombosis
| Arm of the triad | What slide 49 lists under it |
|---|---|
| Venous stasis (alterations in blood flow) | Immobilization (long flights, prolonged sitting, postoperative inactivity), about 20 times the risk · venous insufficiency · heart failure |
| Hypercoagulable state (inherited or acquired) | Factor V Leiden, prothrombin gene mutation, protein C or S deficiency, antithrombin deficiency · cancer · oral contraceptive pill (especially with smoking or obesity) or postmenopausal estrogen replacement therapy · pregnancy |
| Trauma (vascular endothelial injury) | Surgery (especially knee or hip replacement, or hip fracture) · intravenous drug use (lower extremity injection) · smoking · hypertension · trauma and burns |
SHE makes the clot.
S Stasis of venous blood flowH Hypercoagulable stateE Endothelial injury (the slide’s “trauma” arm)
Where it breaks: One risk factor can sit in more than one arm, and the slide files smoking and hypertension under the trauma arm.
| Item (slide 55) | Points |
|---|---|
| Active cancer (treatment or palliation within 6 months) | +1 |
| Bedridden recently more than 3 days, or major surgery within 12 weeks | +1 |
| Calf swelling more than 3 cm compared with the other leg (measured 10 cm below the tibial tuberosity) | +1 |
| Collateral (nonvaricose) superficial veins present | +1 |
| Entire leg swollen | +1 |
| Localized tenderness along the deep venous system | +1 |
| Pitting edema, confined to the symptomatic leg | +1 |
| Paralysis, paresis, or recent plaster immobilization of the lower extremity | +1 |
| Previously documented deep vein thrombosis | +1 |
| Alternative diagnosis to deep vein thrombosis as likely or more likely | −2 |
| Outpatient and emergency department use only, not inpatients (slide 54). Slide 55 shows two versions: the calculator picture lists all ten items; the table picture beside it has nine (no “previously documented deep vein thrombosis”). Travel is not an item. | |
3 C’s and 3 P’s ring the BEL; an Alternative takes 2 away.
C Cancer (active)C Calf swelling more than 3 cmC Collateral superficial veinsP Pitting edema in the symptomatic legP Paralysis, paresis or plasterP Previous deep vein thrombosisB Bedridden more than 3 days or surgery within 12 weeksE Entire leg swollenL Localized deep-vein tendernessA Alternative diagnosis as likely: −2
Where it breaks: Every letter is +1 except A (−2). “Previous deep vein thrombosis” is only in the slide’s calculator picture.
| Total | Likelihood (slide 55) | What to order (slide 56) |
|---|---|---|
| 0 or less | Low | D-dimer: negative → stop; positive → ultrasound of the thigh (negative → stop) |
| 1 to 2 | Moderate | Not on the slide 56 pathway, which shows only low and high risk |
| 3 or more | High | Ultrasound of the thigh (a D-dimer, “if taken”, leads to the same ultrasound whatever its result); if negative, either ultrasound of the lower leg, phlebography, or a repeat thigh ultrasound in 1 week |
Low goes to the lab; high goes to the scanner.
0 or less lab first: the D-dimer rules it out1 to 2 the middle band (no branch on the pathway)3 or more scan first: ultrasound of the thigh
Where it breaks: The pathway picture has no moderate branch; the three cut-offs come from the heading of slide 55’s table.
| Category | Examples on slide 64 | Treat for |
|---|---|---|
| Any acute first episode (slide 63) | Deep vein thrombosis or pulmonary embolism, every patient | Minimum 3 months |
| Provoked by a major transient or reversible risk factor | Surgery under general anesthesia more than 30 minutes · hospitalization or bed rest 3 days or more · major trauma or fracture | 3 months |
| Provoked by a minor transient risk factor | Estrogen therapy · pregnancy · minor surgery · prolonged travel · minor leg injury | 3–6 months |
| Unprovoked first venous thromboembolism | No identifiable risk factor | Indefinite |
The smaller the trigger, the longer the drug.
Floor every first episode gets at least 3 monthsMajor trigger 3 monthsMinor trigger 3–6 monthsNo trigger no end date
Where it breaks: Slide 64 itself names three categories; the 3-month floor comes from slide 63. Prolonged travel is a minor trigger here even though it is not a Wells item.
| Outpatient therapy appropriate for | Outpatient therapy NOT appropriate for |
|---|---|
| Hemodynamically stable | Iliofemoral (proximal) deep vein thrombosis |
| Low bleeding risk | Concurrent symptomatic pulmonary embolism |
| No renal insufficiency | High bleeding risk |
| Good support and reliable (likely to adhere to the treatment plan and follow-up) | Other comorbidities that warrant inpatient care |
Home needs four S’s; the hospital keeps the high clot, the lung clot, the bleeder and the sick.
Stable hemodynamicallySafe low bleeding riskSound kidneys no renal insufficiencySupported good support, reliableHigh clot iliofemoral (proximal)Lung clot concurrent symptomatic pulmonary embolismBleeder high bleeding riskSick other comorbidities needing inpatient care
Where it breaks: The two columns are separate lists, not pairs; kidney function appears only on the outpatient side.
| Triad item (slide 14) | Detail on the slide |
|---|---|
| Claudication | Buttock and hip claudication: aching, may have weakness of the hip or thigh with walking (aortoiliac disease) |
| Absent or diminished femoral pulses | Unilateral or bilateral |
| Erectile dysfunction | Caused by severe aortoiliac disease |
Three L’s when the aorta clogs at its fork: Limp, Lost pulse, Limp.
Limp claudication (buttock and hip)Lost pulse absent or diminished femoral pulsesLimp erectile dysfunction
Where it breaks: The two “limps” are different organs; all three point to aortoiliac disease.
| Index | Interpretation (slide 42) |
|---|---|
| More than 1.3 | Abnormal: calcified artery walls, non-compressible arteries (for example, a diabetic patient) |
| More than 0.9 to 1.3 | Normal |
| 0.4 to 0.9 | Claudication |
| 0 to 0.4 | Rest pain, tissue loss (ulcer, gangrene) |
| How to calculate (slide 43): each leg = its higher ankle pressure (posterior tibial or dorsalis pedis) ÷ the higher arm pressure (either arm); the lower of the two legs is the patient’s overall index. | |
Nine is fine, four is the floor, over 1.3 is stone.
Nine is fine above 0.9 to 1.3 = normalBetween nine and four 0.4–0.9 = claudication (walking hurts)Below the floor 0–0.4 = rest pain, tissue lossStone above 1.3 = calcified, non-compressible
Where it breaks: The slide’s bands share their edges (0.4 and 0.9 each sit in two bands). The calculation note is not part of the rhyme.
| P (slide 61) | What the slides add |
|---|---|
| Pain | Abrupt onset of severe pain (slide 59) |
| Pallor | — |
| Pulselessness | Absent pulses distal to the occlusion |
| Paresthesia | Light-touch sensory fibers are highly susceptible to ischemia; a sensory deficit over the dorsum of the foot is often the earliest neurologic sign |
| Paralysis | Test muscle strength |
| Poikilothermia | Slide 61 also lists a cold, cyanotic extremity |
Artery, nerve, thermostat: three P’s the artery shows you, two the nerve shows you, one the thermostat shows you.
Artery pain, pallor, pulselessnessNerve paresthesia, paralysisThermostat poikilothermia (the cold limb)
Where it breaks: The grouping is ours; the slide simply lists six. The nerve pair is what moves a limb up the Rutherford stages below.
| Stage | Limb | Prognosis | Sensory loss | Muscle weakness | Arterial / venous Doppler | Next step (slides 62–64) |
|---|---|---|---|---|---|---|
| I | Viable | Not immediately threatened | None | None | Audible / audible | Time for vascular imaging (for example computed tomography angiography) |
| IIA | Marginally threatened | Salvageable if promptly treated | Minimal (toes) or none | None | Often inaudible / audible | Time for vascular imaging |
| IIB | Immediately threatened | Salvageable with immediate revascularization | More than the toes, pain at rest | Mild or moderate | Usually inaudible / audible | Evaluate and treat in a surgical suite |
| III | Irreversibly damaged | Major tissue loss or permanent nerve damage inevitable | Profound, anesthetic | Profound, paralysis (rigor) | Inaudible / inaudible | Major amputation; vascular imaging generally not needed |
| Slides disagree on IIA: the slide 65 table (shown) says arterial Doppler “often inaudible” and sensory loss “minimal (toes) or none”; slide 62 says arterial Doppler signals are “often audible”, with “no sensory loss” and “minimal pain (in the toes)”. | ||||||
I is Intact, A is A little, B is Both, III is gone.
I Intact: no sensory loss, no weakness, both signals heardIIA A little: the toes at most, no weakness; time to imageIIB Both: sensory loss beyond the toes AND weakness; straight to the surgical suiteIII gone: profound loss, paralysis, both signals silent; amputate
Where it breaks: The venous signal stays audible until stage III; the IIA arterial signal is the cell the slides disagree on.
| Patient | Definition (slide 72) | Plan (slide 75) |
|---|---|---|
| Symptomatic | Focal neurologic symptoms: transient ischemic attack (focal loss of neurologic function lasting less than 24 hours) or stroke | Surgery if stenosis is more than 70% |
| Asymptomatic | Narrowing in one or both carotids with no ischemic stroke or transient ischemic attack within the last 6 months; they outnumber symptomatic patients 4:1 | Surgery if stenosis is more than 80% and life expectancy is more than 5 years |
| Either, low grade | Stenosis less than 50% | Medical management |
Symptoms lower the bar: 70 with symptoms, 80 (plus 5 years) without, under 50 is medicine.
70 symptomatic: operate above 70%80 + 5 asymptomatic: operate above 80% with more than 5 years to liveUnder 50 medical management for both
Where it breaks: The slide gives no plan for stenosis between these cut-offs.
| Size or growth | What it means |
|---|---|
| Abdominal aortic aneurysm | |
| More than 3 cm | Aneurysmal: the average infrarenal aorta is 2 cm (slide 83); an aneurysm is a localized dilation more than 50% of normal diameter (slide 82) |
| 3.0–3.9 cm | Ultrasound every 3 years (slide 95) |
| 4.0–5.4 cm | Ultrasound or computed tomography every 6–12 months (slide 95) |
| 4.5 cm or larger | Vascular specialist referral for observation and assessment; aneurysmal pain at any size = urgent referral (slide 100) |
| 5.0 cm or larger | Women: elective repair (slide 95). Consider vascular surgery referral (slide 101). Rarely ruptures until it exceeds 5 cm (slide 99). |
| More than 5.5 cm | Men: elective repair (slide 95 reads “>5.5 cm or larger”); increased rupture risk (slide 99) |
| Growth of 0.5 cm in 6 months | Rapid growth: repair (slide 95, “0.5 cm/6 months”); increased rupture risk (slide 99, “> 0.5 cm in six months”) |
| Slides differ on the growth trigger: slide 95 says rapid growth is 0.5 cm/6 months; slide 99 says more than 0.5 cm in six months. Slide 95 also writes the men’s repair size as “>5.5 cm or larger”. | |
| Thoracic aortic aneurysm (root, ascending or descending) | |
| Less than 4.5 cm | Computed tomography or magnetic resonance imaging every 3–5 years (slide 109) |
| 4.5–5.4 cm | Computed tomography or magnetic resonance imaging every 6–12 months (slide 109) |
| Ascending more than 5.5 cm | Surgical repair generally indicated (slide 109) |
| Descending more than 6.0 cm | Surgical repair generally indicated (slide 109) |
| Growth of more than 0.5 cm per year | Surgical repair (slide 109) |
| Any size, symptomatic | Repair all symptomatic thoracic aneurysms; chest or back pain needs urgent imaging (slide 108) |
| Pseudoaneurysm (false aneurysm) | |
| Less than 2 cm | Watch and wait: may undergo spontaneous thrombosis and regression (slide 113). The slide also lists ultrasound-guided thrombin injection to seal the leak. |
Belly: 3 to call it, 4 to scan it, 4.5 to refer it, 5 to fix it (men 5.5). Chest: 5.5 up, 6 down. False: under 2, wait.
3 aneurysm; scan every 3 years to 3.94 4.0–5.4: scan every 6–12 months4.5 refer to vascular5 / 5.5 repair: women 5.0, men above 5.5Half in half 0.5 cm in 6 months: repairChest under 4.5 every 3–5 years; 4.5–5.4 every 6–12 months; repair ascending above 5.5, descending above 6.0, growth above 0.5 cm a year, or any symptomsUnder 2 pseudoaneurysm: watch and wait
Where it breaks: Growth counts per 6 months in the abdomen but per year in the chest.
| Class | Limitation | Slide 14 wording |
|---|---|---|
| I | None | No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation or shortness of breath. |
| II | Slight | Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, shortness of breath or chest pain. |
| III | Marked | Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, shortness of breath or chest pain. |
| IV | Symptoms at rest | Symptoms of heart failure at rest. Any physical activity causes further discomfort. |
Ask where the symptoms start: never, ordinary activity, less than ordinary, at rest.
I never (stairs are fine)II ordinary activity (the stairs)III less than ordinary (across the room)IV at rest (in bed)
Where it breaks: Stairs, room and bed stand in for the slide’s “ordinary” and “less than ordinary” activity; classes II and III are both comfortable at rest.
| Type | Definition (slide 46) |
|---|---|
| Paroxysmal | Less than 1 week; usually ends without treatment |
| Persistent | Continuous for more than 7 days but less than 1 year; needs treatment |
| Long-standing persistent | Continuous for more than 1 year |
| Permanent | Patient and clinician make a joint decision to stop further attempts to restore or maintain sinus rhythm |
A week, a year, a decision.
Paroxysmal Passes on its own, under a weekPersistent Pushed past a week (up to a year): needs treatmentLong-standing past a yearPermanent a Pact to stop trying for sinus rhythm
Where it breaks: Permanent is defined by the decision, not by a duration.
| Letter | Item (slide 51) | Points |
|---|---|---|
| C | Congestive heart failure history | +1 |
| H | Hypertension history | +1 |
| A2 | Age 75 or older | +2 |
| D | Diabetes history | +1 |
| S2 | Stroke, transient ischemic attack or thromboembolism history | +2 |
| V | Vascular disease history (prior myocardial infarction, peripheral artery disease or aortic plaque) | +1 |
| A | Age 65–74 (under 65 scores 0) | +1 |
| Sc | Sex category: female (male scores 0) | +1 |
| Slide 50: a score of 0 in a man or 1 in a woman = low risk, may not require anticoagulation; patients typically require anticoagulation unless bleeding risk is high (slide 49 says “anticoagulation for all”). In the recording she said the point table need not be memorized; know that this score = stroke risk. The table is here so you can score a vignette. | ||
The subscript 2s are the 2-pointers: A2 (75 or older) and S2 (stroke). Everything else is 1; the maximum is 9.
C congestive heart failureH hypertensionA2 age 75 or olderD diabetesS2 stroke, transient ischemic attack, thromboembolismV vascular diseaseA age 65–74Sc sex category: female
Where it breaks: The slide’s picture shows no letters and lists the items in another order (age, sex, heart failure, hypertension, stroke, vascular disease, diabetes). Age is one item with three bands, so a patient scores A2 or A, never both.
| Letter | Item (slide 51) | Points |
|---|---|---|
| H | Hypertension: uncontrolled, systolic more than 160 mmHg | +1 |
| A | Abnormal renal function: dialysis, transplant, creatinine more than 2.26 mg/dL (more than 200 µmol/L) | +1 |
| A | Abnormal liver function: cirrhosis, or bilirubin more than 2 times normal with aspartate aminotransferase, alanine aminotransferase or alkaline phosphatase more than 3 times normal | +1 |
| S | Stroke history | +1 |
| B | Bleeding: prior major bleeding or predisposition to bleeding | +1 |
| L | Labile international normalized ratio: unstable or high values, time in therapeutic range less than 60% | +1 |
| E | Elderly: age more than 65 | +1 |
| D | Drugs predisposing to bleeding: aspirin, clopidogrel, nonsteroidal anti-inflammatory drugs | +1 |
| D | Alcohol use: 8 or more drinks a week | +1 |
| Slide 50: HAS-BLED 3 and up = no anticoagulation; 1 = low risk, anticoagulation okay (a score of 2 is not addressed). Current guidance treats a high score as bleeding risk to correct, not a reason to withhold; the course tests the slide. | ||
Every item is 1 point; A and D each hold two items (kidney and liver; drugs and drink), so the maximum is 9.
H hypertensionA abnormal kidney, abnormal liverS strokeB bleeding historyL labile ratioE elderlyD drugs, drink
Where it breaks: The letters are the standard acronym; the slide’s picture lists the nine items in this order without letters. Age cut-offs differ from CHA2DS2-VASc: above 65 here.
| Block | PR interval | P waves and QRS | QRS width | Rhythm and rate |
|---|---|---|---|---|
| First degree | More than 0.20 s, constant | One P wave for every QRS (all conducted) | Narrow, under 0.12 s | Regular, 60–100 |
| Second degree, Mobitz I (Wenckebach) | Progressively increases from normal to long until a QRS drops | Some P waves not conducted: more P waves than QRS complexes | Narrow, under 0.12 s | No regular underlying rhythm, a pattern with regularly missing QRS; 60–100 |
| Second degree, Mobitz II | Constant, 0.12–0.20 s | More P waves than QRS complexes: random dropped QRS | Narrow, under 0.12 s | Regular apart from random missing QRS; 60–100 |
| Third degree (complete) | Random | No P wave conducted; P waves have no association with the QRS and may hide in the QRS, ST segment or T wave | Narrow or wide | Two separate regular rhythms; ventricular rate usually under 40 |
The block poem, one line per degree.
First “If the R is far from P, then you have a first degree” (long, constant PR)Mobitz I “Longer, longer, longer, drop: then you have a Wenckebach”Mobitz II “If some P’s don’t get through, then you have a Mobitz II” (PR constant)Third “If P’s and Q’s don’t agree, then you have a third degree” (two separate rates)
Where it breaks: “Some P’s don’t get through” is also true of Mobitz I; the PR decides: lengthening (I) versus constant (II).
| Left bundle branch block (slide 24) | Right bundle branch block (slide 29) |
|---|---|
| QRS more than 0.12 s | QRS more than 0.12 s |
| Dominant S wave in V1 (rS pattern) | rsR′ in V1, V2, V3 (“bunny ears”, slide 28) |
| Prolonged R wave peak, more than 0.06 | Slurred S wave in I and aVL |
| Monophasic R in the lateral leads | — |
| Absent Q waves in I, V5, V6 | — |
| Slide 21 (intraventricular delays) lists the QRS as “wide (> 0.20)”; slides 24 and 29 say more than 0.12 s. | |
Both are wide. Right = Rabbit ears in the Right chest leads; Left = a deep S in V1 and a Lone R laterally.
Both QRS more than 0.12 sRabbit ears rsR′ in V1–V3 (right)Slur slurred S in I and aVL (right)Deep S dominant S in V1 (left)Lone R monophasic R in the lateral leads (left)Late R R wave peak more than 0.06 (left)Lacking Q no Q in I, V5, V6 (left)
Where it breaks: The two columns are separate lists, not pairs, except the shared QRS width.
| Term | Definition (slides 39–40) |
|---|---|
| Ventricular tachycardia | 3 or more consecutive premature ventricular contractions; regular, 100–250, no P waves, QRS more than 0.12 s (wide) |
| Non-sustained | Duration less than 30 seconds |
| Sustained | Duration 30 seconds or more, or causes hemodynamic collapse in less than 30 seconds |
| Monomorphic | QRS complexes have the same morphology |
| Polymorphic | QRS morphology varies |
| Torsades de pointes | A polymorphic type in which the QRS complexes appear to “twist” around the baseline; long QT is a risk factor |
3 beats make it; 30 seconds (or a collapse) sustain it.
3 3 or more in a row = ventricular tachycardia30 under 30 s = non-sustained; 30 s or more = sustainedMono / poly one shape / many shapesTwist torsades = polymorphic that twists (long QT)
Where it breaks: A collapse makes it sustained even before 30 seconds.
| Letter | Instability = any ONE of (slide 45) |
|---|---|
| C | Chest pain |
| A | Altered mental status |
| S | Shortness of breath |
| H | Hypotension |
| Unstable monomorphic ventricular tachycardia: check for a pulse; pulse present → synchronized cardioversion; pulseless → defibrillation (slide 45). | |
Unstable patients need CASH, fast.
C chest painA altered mental statusS shortness of breathH hypotension
Where it breaks: One sign is enough. The letters follow the slide’s own order.
| Term | Definition (slide 5) |
|---|---|
| Acute | Inflammation of the pericardial sac lasting less than 4 to 6 weeks |
| Incessant | Symptoms persist more than 4 to 6 weeks, up to 3 months, without a sustained remission |
| Recurrent | Symptoms of acute pericarditis return after a symptom-free interval of 4 to 6 weeks or longer |
| Chronic | Symptoms persist more than 3 months |
Two clocks: 4–6 weeks and 3 months.
Acute under 4–6 weeksIncessant won’t quit: past 4–6 weeks up to 3 months, no remissionRecurrent comes back after 4–6 symptom-free weeksChronic past 3 months
Where it breaks: Recurrent needs a symptom-free gap; incessant never has one.
| Criterion (slide 14: two of four) | What it looks like |
|---|---|
| Sharp substernal chest pain | Pleuritic, worse supine and on inspiration, relieved by leaning forward (slide 13) |
| Pericardial friction rub | Highly specific; triphasic, scratchy or squeaking; loudest over the left sternal border; best heard with the diaphragm; louder leaning forward and holding a breath (slide 17) |
| Suggestive electrocardiogram changes | Widespread ST elevation (slide 14): concave ST elevation and PR depression, with reciprocal ST depression and PR elevation in aVR (slide 19) |
| New or worsening pericardial effusion | The echocardiogram is often normal unless there is an associated pericardial effusion (slide 24) |
| Diagnosis of idiopathic or viral pericarditis is usually clinical (slide 14). | |
Four S’s; any two make the diagnosis.
Sharp sharp substernal chest painScratch pericardial friction rubST widespread ST elevationSac fluid new or worsening effusion
Where it breaks: Troponin and fever are not among the four.
| Stage | Electrocardiogram (slide 22) | When (slide 22) |
|---|---|---|
| 1 | Widespread ST elevation and PR depression, with reciprocal changes in aVR | First two weeks (slide 23: less than 1 week) |
| 2 | ST changes normalize; generalized T-wave flattening | 1 to 3 weeks |
| 3 | Flattened T waves become inverted | 3 to several weeks |
| 4 | Electrocardiogram returns to normal | Several weeks onward |
| Stage 1 timing differs: slide 22 says the first two weeks; the slide 23 picture says less than 1 week (and adds ST elevation under 5 mm, with ST depression and PR elevation in aVR). | ||
Up, flat, flip, fine.
1 Up ST up (PR down)2 Flat ST back to baseline, T waves flatten3 Flip T waves invert4 Fine normal again
Where it breaks: A tracing taken weeks in can already sit at stage 3 or 4.
| Feature | Slide 27 wording |
|---|---|
| Fever | Above 38 °C (100.4 °F) |
| Subacute course | Over days to weeks, without an acute onset of chest pain |
| Tamponade | Evidence suggesting cardiac tamponade |
| Effusion | A moderate to large pericardial effusion |
| Immunosuppressed | Immunosuppressed patients |
| Anticoagulated | Patients on oral anticoagulants |
| Trauma | Acute trauma |
| Not improving | No clinical improvement after 7 days of appropriately dosed nonsteroidal anti-inflammatory drug and colchicine therapy |
| Troponin | Elevated cardiac troponin (suggests myopericarditis or perimyocarditis) |
3 T’s, 2 F’s, 2 S’s and 2 thin shields.
3 T’s Tamponade signs, Trauma, Troponin up2 F’s Fever above 38 °C, Fluid: a moderate to large effusion2 S’s Subacute start, Stalled: no better after 7 days2 thin shields immunosuppressed, on oral anticoagulants
Where it breaks: “Thin shields” is our label for the two patients least able to cope: one with infection, the other with bleeding.
| Treatment failure is defined as (slide 30) |
|---|
| Persistence of fever |
| Pleuritic chest pain |
| New pericardial effusion |
| Worsening of general illness |
| Failure to respond to nonsteroidal anti-inflammatory drug plus colchicine therapy within 1 week suggests a cause other than idiopathic or viral pericarditis (slide 30). |
Still hot, still hurting, newly wet, getting worse after a week: look past the virus.
Hot fever persistsHurting pleuritic chest painWet new pericardial effusionWorse general illness worsening
| Slide 54 wording | Same thing |
|---|---|
| Distant heart sounds | Muffled heart sounds |
| Distended jugular veins | Jugular venous distension |
| Decreased arterial blood pressure | Hypotension |
| In the recording she named a different “triad” (alternans, pulsus paradoxus, Kussmaul sign); slide 54’s three are the Beck triad. | |
Beck’s three D’s, in the slide’s own words.
Distant heart soundsDistended jugular veinsDecreased arterial blood pressure
| Axis (slide 8) | Categories |
|---|---|
| Temporal evolution | Acute: hectically febrile illness from a virulent, invasive organism; typically 3–10 days, rapid onset, high fevers, systemic toxicity; seeds extracardiac sites; death within weeks if untreated. Subacute: indolent; lower fevers, malaise, weight loss over weeks or months; rarely metastasizes (slide 10) |
| Site of infection | Native valve; prosthetic valve; cardiovascular implantable electronic device (vegetation on pacemakers and implantable cardioverter-defibrillators) (slide 5) |
| Cause of infection | The organism, for example methicillin-resistant versus methicillin-susceptible Staphylococcus aureus |
| Predisposing risk factors | For example, people who inject drugs |
Classify it like a news story: when, where, what, who.
When acute or subacuteWhere native valve, prosthetic valve or deviceWhat the organism (resistant or susceptible Staphylococcus aureus)Who the predisposing risk (people who inject drugs)
| Criterion | What counts (slide 22 table) |
|---|---|
| Major criteria | |
| B · Blood cultures positive | Typical organism from two separate blood cultures (viridans streptococci, Streptococcus gallolyticus, HACEK (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella; slide 19) group, Staphylococcus aureus, or community-acquired enterococci without a primary focus); or persistently positive (drawn more than 12 hours apart, or all of 3 or most of 4 or more, first and last at least 1 hour apart); or a single positive culture for Coxiella burnetii or a phase I immunoglobulin G antibody titer above 1:800 |
| E · Endocardial involvement | Positive echocardiogram: oscillating intracardiac mass (on a valve or supporting structures, in the path of regurgitant jets, or on implanted material, with no other anatomic explanation), abscess, or new partial dehiscence of a prosthetic valve; or new valvular regurgitation (an increase or change in a preexisting murmur is not sufficient) |
| Minor criteria | |
| T · Temperature | Fever 38.0 °C (100.4 °F) or higher |
| I · Immunologic phenomena | Glomerulonephritis, Osler nodes, Roth spots, rheumatoid factor |
| M · Microbiologic evidence | A positive blood culture that does not meet a major criterion, or serologic evidence of active infection with an organism consistent with endocarditis (single positive cultures of coagulase-negative staphylococci or diphtheroids, common contaminants, do not count, nor do single positive cultures of organisms that do not cause endocarditis frequently, such as gram-negative bacilli) |
| E · Embolic (vascular) phenomena | Major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctival hemorrhages, Janeway lesions |
| R · Risk factor (predisposition) | Predisposing heart condition (valve stenosis or regurgitation, prosthetic valve, congenital heart disease except an isolated atrial septal defect, a repaired ventricular septal defect or a closed patent ductus arteriosus, prior endocarditis, hypertrophic cardiomyopathy) or injection drug use |
| Verdict | |
| Definite | 2 major, or 1 major + 3 minor, or 5 minor (slide 22 footnote and the pictures on slides 22–23) |
| Possible | 1 major + 1 minor, or 3 minor (slide 23 picture) |
| The slide 23 mnemonic picture writes fever as “> 38 °C” and the culture criterion as “positive > 2 times 12 hrs apart”; the slide 22 table says 38.0 °C or higher and gives the fuller rules above. The slides give no “rejected” rule. | |
BE TIMER (slide 23’s own mnemonic): major = BE, minor = TIMER. Definite = two majors, one major plus three minors, or a full hand of five minors.
B blood culturesE echocardiogram: endocardial involvementT temperature 38.0 °C or moreI immunologic: Osler, Roth, glomerulonephritis, rheumatoid factorM microbiologic: a culture short of majorE embolic: Janeway, emboli, infarcts, mycotic aneurysmR risk: heart condition or injection drug use
Where it breaks: TIMER reorders slide 22’s minor list (predisposition, fever, vascular, immunologic, microbiologic). Osler nodes (painful, slide 13) are immunologic; Janeway lesions (nontender, slide 13) are embolic. Possible = 1 major + 1 minor, or 3 minor.
| Term | What you need to know |
|---|---|
| ★ Virchow triad | Why a clot forms in a vein: venous stasis + hypercoagulable state + endothelial trauma (vascular endothelial injury). Three big overarching categories; she named all three three times in a row. Several arms often act together (a hip fracture is trauma, then immobilization). |
| Stasis (alterations in blood flow) | Immobilization: long flights, prolonged sitting, postoperative inactivity (the deck gives about a 20-fold risk). Venous insufficiency. Heart failure. |
| Hypercoagulable state | Inherited: factor V Leiden = the most common inherited cause; prothrombin gene mutation; protein C or protein S deficiency; antithrombin deficiency. Acquired: cancer; oral contraceptive pill (more if she also smokes or is obese) or postmenopausal estrogen replacement therapy; pregnancy. |
| Endothelial trauma | Surgery, especially knee or hip replacement or hip fracture repair; trauma and burns; intravenous drug use (lower extremity injection). The slide also files smoking and hypertension here. |
| Triad on a case | Long car ride or a cast → stasis. Cancer, pregnancy, estrogen or a known clotting disorder → hypercoagulable state. Recent surgery, fracture, burns or injection drug use → endothelial trauma. |
| ★ Wells criteria: use | Stratifies the pretest likelihood of deep vein thrombosis. Outpatient and emergency department only — not inpatients. She said the criteria come straight from the risk factors, so know the risk factors best. |
| Wells: +1 each | Active cancer (treatment or palliation within 6 months) · bedridden more than 3 days or major surgery within 12 weeks · calf swelling more than 3 cm versus the other leg (measured 10 cm below the tibial tuberosity) · collateral (nonvaricose) superficial veins · entire leg swollen · localized tenderness along the deep venous system · pitting edema confined to the symptomatic leg · paralysis, paresis or recent plaster immobilization of the lower extremity · previously documented deep vein thrombosis. |
| Wells: −2 | Alternative diagnosis at least as likely as deep vein thrombosis = −2. |
| Wells: score → order | Zero or less = low → D-dimer first (negative: stop; positive: ultrasound). 1 to 2 = moderate (the pathway picture shows only low and high). 3 or more = high → skip the D-dimer, order the ultrasound. |
| Wells: pathway | Low: D-dimer negative = stop; positive = ultrasound of the thigh; negative = stop. High: ultrasound of the thigh; if negative, either ultrasound of the lower leg, phlebography (venography), or a repeat thigh ultrasound in 1 week. |
| Travel is NOT a criterion | “Bedridden” means after surgery or immobilized in a cast or plaster, so a long flight scores nothing (travel is still a risk factor and a minor transient trigger for treatment duration). |
| ★ D-dimer | Sensitive but not specific. A raised D-dimer means increased fibrinolysis somewhere, not necessarily a leg clot; a rule-out test for deep vein thrombosis and pulmonary embolism; the first test for a low Wells score. Know what you will do next with either result. Contrast venography (gold standard, invasive) was replaced by venous duplex ultrasound. |
| Term | What you need to know |
|---|---|
| Epidemiology | Clot in the deep veins, usually the legs; lower extremity about 10 times more common than upper. Starts in the calf and moves proximally (popliteal, femoral, iliac). Proximal: femoral and popliteal; distal: peroneal; pregnancy: pelvic veins. Upper extremity 5–10% of all, from pacemakers, implantable cardiac defibrillators, central venous catheters. Pulmonary embolism: up to 6% upper vs 15–30% lower. |
| Other risk factors | ★ Personal or family history of clot — a prior episode markedly raises the recurrence risk (the slide says about 30 times; several-fold is true). Age older than 60; obesity; slightly more males; smoking, heart failure, hypertension, chronic kidney disease, chronic obstructive pulmonary disease, inflammatory bowel disease; cancer and chemotherapy; air travel and sedentary life; estrogen contraceptives, postmenopausal hormone replacement, first 6–12 weeks postpartum. |
| Presentation | Swelling (97% sensitive), pain (86%), warmth (72%), ± erythema; a calf cramp that persists and worsens over days. Distal clot: calf only; proximal: calf or whole leg. Homan sign is neither sensitive nor specific. Upper extremity: arm swelling and discomfort. |
| Differential | Ruptured popliteal (Baker) cyst: severe sudden calf discomfort. Cellulitis: erythema, possibly fever and chills. Post-thrombotic syndrome: chronic venous insufficiency 6–24 months after a clot. Superficial thrombophlebitis: tender cord. Lymphedema: chronic edema, pelvic surgery, malignancy or radiation. Calf muscle tear: inciting injury, ankle bruising. Drug-induced edema (amlodipine): often bilateral, no inflammation. |
| Diagnosis | Wells score (top card), then D-dimer and/or venous duplex ultrasound of the involved extremity; say why you are ordering it. |
| ★ Treatment: mainstay | Anticoagulation is the mainstay — “the biggest thing that we need to know.” Thrombolysis and thrombectomy are add-ons for selected large clots, never routine. Strategies: (1) heparin, then bridge to warfarin; (2) parenteral for 5 days, then dabigatran or edoxaban; (3) oral monotherapy, loading then maintenance: rivaroxaban or apixaban. |
| Anticoagulant classes | Low molecular weight heparin: enoxaparin. Unfractionated heparin: intravenous bolus then infusion, adjusted by the activated partial thromboplastin time. Fondaparinux: indirect factor Xa inhibitor. Rivaroxaban, apixaban: direct factor Xa inhibitors. Dabigatran: direct thrombin inhibitor. Warfarin: vitamin K antagonist, monitored by the international normalized ratio. |
| Contraindications | Active bleeding, acute intracranial hemorrhage, major trauma, severe bleeding disorders. |
| ★ Duration | Minimum 3 months for every first episode. Major transient (reversible) factor (general anesthesia over 30 minutes, hospitalization or bed rest 3 days or more, major trauma or fracture): 3 months. Minor transient factor (estrogen, pregnancy, minor surgery, prolonged travel, minor leg injury): 3–6 months. Unprovoked first clot: indefinite (an undiscovered clotting condition cannot be excluded). |
| ★ Outpatient | Yes: hemodynamically stable, low bleeding risk, no renal insufficiency, good support and reliable adherence. No: iliofemoral (proximal) clot, concurrent symptomatic pulmonary embolism, high bleeding risk, other comorbidities needing inpatient care. Options: rivaroxaban; apixaban; low molecular weight heparin or fondaparinux 5 days then dabigatran or edoxaban; or either heparin 5 days overlapping warfarin until the international normalized ratio is above 2. Creatinine clearance below 30 mL/min: hospitalize; unfractionated heparin + warfarin overlapped at least 5 days and until the ratio is above 2 for 24 hours. |
| Reversal agents | Unfractionated or low molecular weight heparin: protamine sulfate. Dabigatran: idarucizumab. Apixaban, rivaroxaban: andexanet alfa. Warfarin: four-factor prothrombin complex concentrate, fresh frozen plasma or intravenous vitamin K; oral vitamin K is the usual outpatient choice. Bleeding is the most serious adverse effect. |
| Vena cava filter | Inferior vena cava filter only with an acute proximal lower extremity clot and active bleeding, or when anticoagulation is otherwise contraindicated; keeps the clot from traveling to the lungs. |
| Prevention | Intermittent pneumatic compression (sequential compression devices), especially when immobilized after surgery or in a long hospital stay. It does the calf muscles’ job so blood does not stagnate: it treats the stasis arm of the triad. |
| Complications | Pulmonary embolism = the biggest: ask every patient about breathing difficulty right away. Post-thrombotic syndrome (chronic venous insufficiency, 6–24 months later). Recurrence. Bleeding from treatment. Fatal pulmonary embolism without adequate treatment: under 1% (clot alone), about 3% (non-massive), about 9% (massive). |
| Term | What you need to know |
|---|---|
| What | Severe manifestation of venous hypertension (called post-thrombotic syndrome when it follows a clot): edema, skin changes (hyperpigmentation, dermatitis, lipodermatosclerosis) and ulceration from reflux and/or obstruction. Primary = wall or valve abnormality; secondary = prior deep vein thrombosis. |
| Causes | ★ Prior deep vein thrombosis = the most common cause (about 25% have no known clot; ask about leg trauma or surgery). Also progressive superficial venous reflux, pelvic vein obstruction, arteriovenous fistula. Risk factors: advancing age, female, family history, ligamentous laxity (flat feet), higher body mass index, smoking, leg trauma, higher parity, high estrogen states. |
| Presentation | Progressive pitting edema of the lower leg is the primary symptom. Dull discomfort, heaviness, throbbing, burning, pruritus from the medial malleolus; worse standing or sitting with feet dependent, relieved by elevation and walking. Grade and document the pitting. |
| Skin findings | Stasis dermatitis: pruritic, eczematous; earliest sign is erythema, scaling and slight hyperpigmentation above the medial malleolus. Hemosiderin staining: brown or blue-gray, separates venous from arterial. Lipodermatosclerosis: firm, indurated, skin tacked down, medial ankle, may form a constrictive band. Cellulitis: blanching erythema, hard to diagnose — outline and date it. |
| Venous ulcer | Above the ankle, medial or anterior; painful; clean base, fibrinous exudate, serous drainage. Heals with a thin scar that breaks down easily. Arterial ulcers: dry, punched out, painful at the toes and lateral ankle. |
| Differential | Heart failure, chronic kidney disease, decompensated liver disease: bilateral edema. Drug edema: calcium channel blockers, nonsteroidal anti-inflammatory drugs, thiazolidinediones. Lymphedema: unilateral, no varicosities. Lipedema: bilateral symmetric, just above the ankles, women. Other ulcers: diabetic neuropathic, arterial, autoimmune, sickle cell anemia, erythema induratum. Punch biopsy if unsure. |
| Work-up | Venous duplex ultrasound first: patency (clot?) and valvular competence (reflux?). ★ Arterial pulse examination and ankle-brachial index for any leg wound and older patients: not to diagnose the venous disease but to rule out peripheral artery disease before compression. Cross-sectional venography if ultrasound falls short; catheter venography (gold standard) only before an intervention. |
| Management | Always nonoperative first. Feet elevated ABOVE heart level; daily walking and ankle flexion; skin care with emollients (mid-potency topical corticosteroid for stasis dermatitis); ★ compression = standard treatment, graduated (tightest at the ankle); cellulitis: oral antibiotics (cephalexin or clindamycin). Ulcers need edema control and compression, wound care referral, 4–6 months to heal. No oral drug proven; surgery occludes or removes vessels. |
| Refer to vascular | Arterial insufficiency (same-day); nonhealing ulcers; recurrent ulcers; persistent stasis dermatitis; suspected contact dermatitis; diagnostic doubt; significant saphenous reflux; long-term edema control. |
| Term | What you need to know |
|---|---|
| What | Dilated, tortuous superficial veins from venous reflux and venous hypertension; most commonly the great saphenous vein, also the short saphenous vein. |
| Risk factors | ★ Family history = the most common predisposing factor. Prolonged standing or heavy lifting; women after pregnancy. |
| Symptoms | ★ Dull, achy heaviness or fatigue brought on by standing = the most common symptom. Itching above the ankle or over the veins; may be asymptomatic. Long-standing varicose veins can progress to chronic venous insufficiency. |
| Exam | Dilated, tortuous, palpable veins of the thigh and calf, seen standing; may be tender. |
| Diagnosis | Clinical: examine the leg in a dependent position. Venous duplex (Doppler) ultrasound confirms and maps the extent of reflux. |
| Management | Isolated varicose veins: elevation, exercise, compression, rule out arterial disease before compression; stockings for weeks to months before ablation. Goal = symptoms and appearance; they often recur. Procedures: sclerotherapy, vein stripping, laser or radiofrequency catheter. |
| Term | What you need to know |
|---|---|
| Definitions | Phlebitis = inflammation of the vein wall without thrombus. Thrombophlebitis = phlebitis with thrombus. Told apart because treatment differs. |
| Risk factors | Varicose veins = the most common cause in the lower extremity. Recent intravenous catheter use (peripherally inserted central catheter most common) = the most common cause in the upper extremity. Inactivity; local trauma or procedure on superficial veins; pregnancy or estrogen; malignancy or hypercoagulable state; prior superficial vein thrombosis without varicose veins. |
| Presentation | Tenderness, pain, induration and erythema along a superficial vein; an indurated palpable cord with warmth and erythema; you can trace the vein. |
| Septic (suppurative) | Infection within the vein: high fever, fluctuance, purulent drainage, or erythema extending well beyond the vein margin. Uncommon without prior venous cannulation, so ask about a recent intravenous line. The deck gives no treatment; a missed infection can leave the patient septic. |
| Diagnosis | History and examination, confirmed by venous duplex ultrasound (gold standard): noncompressible superficial vein with wall thickening. Wall thickening alone = phlebitis; with a clot inside = thrombophlebitis. |
| ★ Treatment | Nonsteroidal anti-inflammatory drugs first (ibuprofen, diclofenac), warm compresses, compression, elevation. Anticoagulation only for extensive clot burden or intermediate or higher thrombosis risk (unfractionated heparin, enoxaparin, fondaparinux). Repeat examination in 7–10 days; repeat duplex ultrasound if signs persist or worsen. |
| Prognosis | Rarely causes serious complications; rarely embolizes. Counsel: patients worry it is a clot. |
| Term | What you need to know |
|---|---|
| What | Abnormal artery-to-vein connection that bypasses the capillary bed; created (hemodialysis), acquired (iatrogenic, trauma) or congenital. |
| Created (dialysis) | ★ Upper extremity fistulas are the ones most commonly created for hemodialysis access (upper arm or forearm, preferred over the leg). Healthy: diffuse thrill and soft bruit, both systolic and diastolic; collapses completely on arm elevation. Cannot hear a bruit: refer. |
| Acquired (iatrogenic) | Most common in the lower extremity, the femoral vessels, after groin access for percutaneous procedures such as cardiac catheterization. Examine the puncture site with a complete lower extremity vascular examination; compare pulses with the pre-procedure pulses. |
| Diagnosis | Physical examination; duplex ultrasound confirms a suspected iatrogenic fistula; computed tomography angiography or angiography gives location and size. |
| Nicoladoni-Branham sign | Compressing a large fistula slows the heart rate (reflex). Do not hold the fistula closed to demonstrate it on a patient. |
| Complications | Watch for infection, chronic venous insufficiency, heart failure and ischemia. |
| Management | Acquired: surgical, remove the fistula or decrease its size. Congenital: hard to treat (many communications); elastic support hose, sometimes embolization. Primary care: keep it free of infection, decide congenital versus acquired, find out how, refer. |
| Term | What you need to know |
|---|---|
| Who | Older than 60 with no other risk factors, or 50 with risk factors; males > females; half also have coronary artery disease. Smoking = three times the risk; elevated homocysteine = earlier atherosclerosis. |
| Claudication | Activity pain relieved by rest in about 10 minutes, analogous to angina. Site = level: buttock/hip = aortoiliac; thigh = common femoral; upper two-thirds of calf = superficial femoral (most common); lower third of calf = popliteal; foot = tibial/peroneal. |
| Leriche triad | Claudication + absent or diminished femoral pulses + erectile dysfunction (aortoiliac). |
| Exam | Dry, thin, shiny skin; hair and nail loss; atrophy; cool limb (temperature line ≈ level); pulses gone below the stenosis; capillary refill > 2 s; bruits. Buerger: leg up 45° for 1 minute → pallor; dangle → dependent rubor. |
| Ankle-brachial index | Initial bedside test. Higher ankle ÷ higher arm; the lower leg is the overall index. 0.9–1.3 normal · 0.4–0.9 claudication · 0–0.4 rest pain / tissue loss · > 1.3 abnormal (calcified, non-compressible — diabetes). |
| Imaging | Duplex ultrasound = mainstay initial imaging (no contrast, no radiation). Computed tomography angiography: contrast allergy or poor renal function is a relative contraindication (a caution that may steer to another study). Magnetic resonance angiography: the contrast-allergy alternative; classically no with pacemaker or intracranial aneurysm clips, though some newer devices and clips are scan-safe. Conventional angiography = gold standard, used to guide intervention. |
| Treatment | Stop smoking; blood pressure < 130/80 in current guidance (older teaching: < 140/90, or < 130/80 with diabetes or renal failure); diabetes and weight control; supervised exercise (beats home-based) 30–45 min ×3/week. Aspirin, clopidogrel, cilostazol; statins (older teaching: simvastatin or pravastatin; current guidance prefers high-intensity atorvastatin or rosuvastatin); low-density lipoprotein classically < 100, < 70 high risk, current guidance favors < 70; pentoxifylline; folic acid + B12 + B6 for high homocysteine (lowers it but has not been shown to reduce heart attacks or strokes). |
| Revascularize when | Disabling claudication despite exercise and drugs: angioplasty ± stent, atherectomy; bypass (saphenous vein or synthetic) mainly for critical limb ischemia; endarterectomy; amputation. |
| Term | What you need to know |
|---|---|
| Rest pain | Constant, burning, forefoot and toes, worse elevated or reclining, wakes at night, narcotics fail. Relieved by dangling the leg or walking (the paradox). |
| Ulcers & gangrene | Ulcers at toe tips, between digits, metatarsal heads: dry, punched out, painful, little bleeding; osteomyelitis risk. Dry gangrene: hard, clear demarcation. Wet gangrene = surgical emergency (moist, edema, blisters, sepsis; usually a mixed bacterial infection, and clostridial gas gangrene is one form). |
| Acute limb ischemia | Sudden occlusion of a previously patent artery — vascular emergency. Emboli: heart is the source in 80–90% (atrial fibrillation, post-infarct ventricular thrombus). Six P’s: pain, pallor, pulselessness, paresthesia, paralysis, poikilothermia. Earliest neurologic sign: sensory loss over the dorsum of the foot. |
| Rutherford | I viable · IIA salvageable if prompt (no sensory loss, no weakness) · IIB salvageable only with immediate revascularization → surgical suite · III irreversible → major amputation, no imaging needed. (IIA arterial Doppler: slides disagree.) |
| Treat | Immediate vascular surgery consult + intravenous heparin; catheter-directed thrombolysis (alteplase) if < 14 days; thromboembolectomy; bypass; amputation. |
| Blue toe | Atheroembolism (cholesterol, fibrin, platelets from proximal plaque): painful blue toe, livedo reticularis — distal pulses still palpable. |
| Term | What you need to know |
|---|---|
| Why it matters | Roughly 10–20% of ischemic strokes (the slide’s 80% of noncardioembolic strokes is overstated); strokes mostly from plaque rupture. Asymptomatic outnumber symptomatic 4:1. |
| Symptoms | Transient ischemic attack (classically < 24 h; defined by no tissue injury), stroke. Auscultate each carotid separately, breath held. |
| Tests | Duplex ultrasonography = initial screening and follow-up. Computed tomography / magnetic resonance angiography. Digital subtraction angiography = gold standard, not for screening. |
| Treat | < 50%: medical (antiplatelets, blood pressure, glucose, statins, stop smoking — nearly doubles stroke risk). Surgery: symptomatic > 70% or asymptomatic > 80% with life expectancy > 5 years. Endarterectomy = gold standard (stroke or nerve damage); stenting for poor surgical candidates. |
| Term | What you need to know |
|---|---|
| Definition | Dilation > 50% of normal. Infrarenal aorta 2 cm; > 3 cm = aneurysm; 90% infrarenal. True = all three layers (saccular or fusiform). |
| Abdominal: risk | Smoking ever = strongest; male (2:1 under 80, 1:1 over 80); age; Caucasian; atherosclerosis; hypertension; family history; other aneurysms. Protective: female, non-Caucasian, diabetes (but women rupture more). 15,000 deaths/year. |
| Abdominal: signs | Mostly incidental. Expansion pain (hypogastrium, back, flank, groin), early satiety, blue toe. Rupture triad (50%): pain + pulsatile mass (virtually diagnostic) + hypotension; Grey Turner sign (flank ecchymosis). Bruit nonspecific. |
| Abdominal: tests | Ultrasound = initial screening and serial size. X-ray calcified outline 75%. Computed tomography angiography = best diagnostic and planning study. Magnetic resonance imaging for stable dye-allergic patients. Type and crossmatch. |
| Abdominal: sizes | 3.0–3.9 cm ultrasound every 3 years; 4.0–5.4 cm every 6–12 months. Specialist at 4.5 cm; urgent for pain at any size. Repair: ≥ 5.0 cm women, > 5.5 cm men, or 0.5 cm growth in 6 months. Rupture rare < 5 cm. |
| Abdominal: treat | Stop smoking, aggressive blood pressure control, moderate exercise. Endovascular or open repair. Symptomatic unruptured: large-bore lines, pain and blood pressure control (beta blocker), repair. Ruptured: surgical emergency — large-bore lines, type and crossmatch. |
| Thoracic | Hypertension common; mostly incidental on chest X-ray (widened mediastinum). Ascending → aortic regurgitation, heart failure; arch → hoarseness; descending → dysphagia, stridor, cough. Computed tomography angiography most used. Beta blockers, blood pressure control; urgent imaging for pain. Repair all symptomatic; ascending > 5.5, descending > 6.0 cm, growth > 0.5 cm/year. |
| Pseudoaneurysm | Blood outside the wall after arterial rupture — femoral artery after catheterization. Thin wall, irregular, hematoma. < 2 cm watch; ultrasound-guided thrombin injection. |
| Dissection | Intimal tear → false lumen in the media. 60s–70s (younger in Marfan), male, hypertension. Sudden tearing chest pain that moves; syncope; aortic regurgitation. Electrocardiogram may be normal; computed tomography chest and abdomen. Systolic 100–120 mmHg using esmolol first, nitroprusside added if still high; surgery; high untreated mortality. |
| Term | What you need to know |
|---|---|
| ★ His study instruction | At the close (2:07:05): study the numbers, genes, most likely causes, best diagnostics and gold standards. Take-home (2:07:26): cardiomyopathy is disease of the muscle itself; sort every case into dilated, hypertrophic or restrictive and decide genetic versus secondary. |
| ★ Best test | Dilated: echocardiogram is definitive: thin dilated walls, ejection fraction < 40% (58:27). Myocarditis: endomyocardial biopsy = gold standard even though rarely done (1:26:09); gadolinium magnetic resonance imaging shows the extent of inflammation (1:25:53). Hypertrophic: echocardiogram is the test of choice (1:38:54); systolic anterior motion is the telltale sign of obstruction (1:31:24). Restrictive: echocardiogram can look normal, so step to magnetic resonance imaging (1:58:21). Takotsubo: mid and apical hypokinesis or akinesis (2:02:41). |
| ★ Numbers he read | Dilated: 10,000 deaths and 46,000 hospitalizations a year; ages 20–60; familial up to 35%; ejection fraction < 40%; defibrillator at < 35% on optimized therapy; 50% dead at 5 years once symptomatic. Myocarditis: viral = 20% of dilated cardiomyopathy; one third later develop it. Hypertrophic: 1 in 500; at least 1,500 mutations; > 80% of sudden deaths are ventricular fibrillation; wall 1.5 cm or more. Takotsubo: 90% postmenopausal women. |
| ★ Can't miss, and what he stressed | Can't miss: hypertrophic cardiomyopathy, so syncope, especially in a young athlete, needs a work-up (1:33:35). Stressed: family history is “extremely important”, primary relatives first (51:26); alcohol is one of the few causes of dilated cardiomyopathy that can recover (47:50); constrictive pericarditis must be differentiated from restrictive cardiomyopathy (1:56:11). |
| ★ Exercise (his last answer) | Obstructive hypertrophic cardiomyopathy: no strenuous activity until it is worked up (2:10:39). The classic slide advice is mild to moderate, noncompetitive activity; current guidance encourages regular mild to moderate exercise and makes strenuous or competitive sports a shared decision: do not key “no exercise at all”. Heart failure from other causes: be active (2:11:00). |
| ★ Recording vs slide | Normal electrocardiogram in dilated cardiomyopathy: slide says it “almost rules it out”; he said it does not (57:56). Truth: unlikely, not excluded. Hypertrophic: nitrates and positive inotropes avoided; diuretics only with care (he said stay away). Amiodarone is an adjunct; the defibrillator is the proven sudden-death device. |
| Term | What you need to know |
|---|---|
| ★ What | Most common cardiomyopathy: dilated, poorly contracting ventricle(s) without severe coronary disease or pressure/volume overload → systolic failure, globular heart; mitral (early) and tricuspid regurgitation. |
| ★ Who / why | Ages 20–60, male, high in African Americans. Idiopathic; familial up to 35% (autosomal dominant); viral or Chagas myocarditis; chemotherapy; alcohol (can recover if stopped; 47:50); thiamine deficiency; lupus, rheumatoid arthritis; peripartum (last trimester to 6 months after delivery). Idiopathic = main indication for transplant. |
| Signs | Progressive exertional dyspnea, orthopnea, paroxysmal nocturnal dyspnea, edema; laterally displaced impulse, third heart sound, regurgitant murmurs, narrow pulse pressure, jugular distension, hepatojugular reflux. |
| ★ Tests | Electrocardiogram usually abnormal; a normal one makes it unlikely but does not exclude it (slide 37: “will almost rule out”; Carter: “doesn’t rule out anything”, 57:56). Echo = definitive: dilated thin walls, ejection fraction < 40% (58:27). X-ray: cardiomegaly, Kerley B lines. B-type natriuretic peptide < 100 pg/mL makes heart failure unlikely (the slide says excludes; it does not strictly rule it out). Magnetic resonance imaging for inflammatory or infiltrative causes; biopsy rarely. |
| ★ Treat | Slide 42 list: angiotensin-converting enzyme inhibitors, beta blockers, angiotensin receptor blockers, spironolactone, sacubitril/valsartan, nitrates, diuretics, digoxin (second line), antiarrhythmics, anticoagulants. Defibrillator if ejection fraction < 35% after maximal therapy (1:02:33); biventricular pacemaker; assist device (bridge or destination); transplant. |
| ★ Teach / outlook | Remove the cause; sodium < 2 g/day; genetic counseling if familial. 50% dead at 5 years once symptomatic (1:06:44). |
| Term | What you need to know |
|---|---|
| Myocarditis: who | Otherwise healthy, young males; flulike illness 1–2 weeks before; viral most frequent (Coxsackie B, parvovirus B19, human herpesvirus 6, COVID-19 (coronavirus disease 2019)...). Viral myocarditis = 20% of dilated cardiomyopathy. |
| Myocarditis: picture | New heart failure or cardiogenic shock with no prior heart disease; palpitations, syncope, sudden death (ventricular arrhythmia, heart block). |
| ★ Myocarditis: tests | Troponin, leukocytosis, sedimentation rate, echo; angiography to exclude ischemia; gadolinium magnetic resonance imaging (best for the extent, 1:25:53). Endomyocardial biopsy = gold standard (1:26:09) once other causes are excluded, for unexplained deterioration not responding to treatment. |
| ★ Myocarditis: treat | Supportive care is the mainstay; stabilize. Most mild cases recover; one third later develop dilated cardiomyopathy (1:21:57). |
| ★ Takotsubo | 90% postmenopausal women (2:01:12) after a big emotional or physical stressor; low cardiac risk. Mimics acute coronary syndrome: chest pain, dyspnea; troponin up; ST elevation, T inversion; echo mid and apical hypokinesis. Confirmed by catheterization: normal coronaries. Treat by the acute coronary syndrome protocol, admit to cardiology (2:03:16); beta blockers. Most recover completely (2:03:39). |
| Term | What you need to know |
|---|---|
| What / who | Unexplained left ventricular hypertrophy, asymmetric septal. Autosomal dominant (sarcomere genes); 1 in 500; male. Leading cause of sudden death in preadolescents and adolescents (extreme exertion; > 80% ventricular fibrillation). |
| ★ Obstruction | Septum narrows the outflow tract + systolic anterior motion of the anterior mitral leaflet → mid-systolic obstruction. Systolic anterior motion on echo = the telltale sign (1:31:24). |
| ★ Symptoms | Dyspnea (commonest), palpitations, exertional syncope / presyncope on standing = high sudden-death risk, urgent work-up (1:33:35), angina without coronary disease. |
| Signs | Normal blood pressure and rate; pulsus bisferiens (double peak); forceful sustained apex; fourth heart sound. Crescendo-decrescendo murmur, left sternal border 3rd–4th space, to the suprasternal notch, not the carotids. |
| Maneuvers | More blood in the heart = softer; less = louder. Squat, leg raise, handgrip → softer. Valsalva, standing, amyl nitrite → louder. Breathing: no effect. |
| ★ Tests | Echocardiography = test of choice (1:38:54): wall ≥ 1.5 cm, septal pattern, small cavity, ejection fraction normal (> 75% late). Electrocardiogram: inferior and lateral Q waves, left axis deviation. Magnetic resonance imaging if echo questionable; 24–48 h ambulatory monitor; catheterization only before invasive therapy; genetic testing does not change treatment. |
| ★ Treat | Beta blocker first, then verapamil or diltiazem. AVOID nitrates, dehydrating diuretics, digoxin, epinephrine, norepinephrine (1:43:49). Amiodarone (slide 78: reduces sudden death), disopyramide, defibrillator; atrial fibrillation → anticoagulate. Myectomy or alcohol septal ablation (months to thin). |
| ★ Teach | Individualized: regular mild to moderate exercise encouraged, strenuous or competitive sports by shared decision (classically noncompetitive only; suspected obstructive disease: no strenuous activity until worked up, 2:10:39); stay hydrated (1:46:52); avoid excess alcohol. Sudden death = leading cause of death. |
| Term | What you need to know |
|---|---|
| ★ What | Least common. Stiff, normal-size ventricles; big atria, atrial fibrillation; ejection fraction preserved until late; right-sided failure dominates; heart block from nodal fibrosis. Poorest prognosis of all (1:59:32). |
| ★ Causes | Amyloidosis (most common in the United States; 1:50:28), hemochromatosis, sarcoidosis, mediastinal radiation, chemotherapy; idiopathic; genetic. |
| ★ Signs | Late presentation; hepatomegaly, ascites, pedal edema; prefers sitting; raised jugular venous pressure; Kussmaul sign (jugular pressure rises with inspiration; 1:55:08); fourth heart sound if no regurgitation. |
| ★ Tests | Electrocardiogram: low QRS voltage in amyloid. Echo: big atria, preserved function — not definitive, can look normal (1:58:01). Cardiac magnetic resonance imaging helps separate it from constrictive pericarditis (a thickened pericardium points to constrictive pericarditis, though constriction can occur with a normal-thickness pericardium); constrictive pericarditis must be differentiated (1:56:11). Biopsy when all else is negative. |
| Treat | Treat the cause; diuretics with caution (preload-dependent); beta blockers, verapamil or diltiazem (may help: longer filling time, better relaxation); anticoagulate atrial thrombi; pacemaker for heart block; transplant. |
| ★ Populations | Adolescent: genetic screening for hypertrophic cardiomyopathy, activity restriction if high risk (2:04:07). Adult: guideline-directed therapy, devices, sodium restriction, alcohol cessation, assist device or transplant. Elderly: tailored to frailty, cautious diuretics and vasodilators, symptom control (“better days”, 2:05:18), palliative discussions. Rehab and hospice referral in end-stage disease. |
| Term | What you need to know |
|---|---|
| ★ How she tests | Few name-the-rhythm questions: see the strip, then what would you do, or what is a risk factor for it (0:53). Medications are tested, doses are not (1:22, 1:32): know the first-line and second-line drug, for example atropine first for unstable sinus bradycardia (2:24). |
| ★ First moves | Stable supraventricular tachycardia: vagal maneuver, then adenosine (up to twice) (38:44–38:54). Unstable: synchronized cardioversion (40:44). Unstable sinus bradycardia: atropine, then a temporary pacemaker, then a permanent one (15:14). Instability = chest pain, altered mental status, shortness of breath, hypotension (37:22; Lecture 30 slide 45). |
| ★ Wolff-Parkinson-White | Her “very important point” (1:08:52). Delta wave only in sinus rhythm, not during the tachycardia (1:10:18). Pathway unknown: treat as supraventricular tachycardia (1:12:48). Known pathway, or adenosine reveals pre-excited atrial fibrillation: intravenous procainamide, never adenosine (1:13:06; slide 37). Atrial fibrillation + Wolff-Parkinson-White = the worst combination (1:35:50). Definitive: ablate the pathway (1:14:47). |
| ★ Tachy-brady = atrial fibrillation | The fast rhythm in tachy-brady syndrome is usually atrial fibrillation: she said it again and again and asked it as a question (31:09, 31:25). Pacemaker when the pauses are symptomatic, long or frequent (33:03); add a defibrillator if the fast rhythm is ventricular tachycardia (33:23). |
| ★ Atrial fibrillation: rate first | Goal number one is rate control (1:30:24, 1:30:59), not converting the rhythm (1:30:46). Rapid ventricular response: intravenous (1:30:27); stable without it: by mouth (1:31:39). Cardioversion only after 21 days of anticoagulation (1:33:00). Score tables: do not memorize (1:33:24); know CHA2DS2-VASc = stroke risk, HAS-BLED = bleeding risk. |
| ★ Not tested; slide wins | Not examined: doses; the narrow-complex algorithm (slide 27; 45:17); the score components (slide 51); what triggers a reentry loop (1:05:22); which part of the node gives which junctional P-wave position (1:40:13); pause counts in sick sinus syndrome (32:27). Slide wins: CHA2DS2-VASc 0 (man) or 1 (woman) is low risk (she said anticoagulate, 1:34:02). A high HAS-BLED score flags bleeding risk to correct; slide 50 and she (1:34:26) withhold anticoagulation, so her exam may key that. |
| Term | What you need to know |
|---|---|
| Paper | Small box 0.04 s; large box 0.20 s; 25 small boxes = 1 s. Normal: PR 0.12–0.20, QRS under 0.12, P under 0.12 (best in V1). Count-off 300, 150, 100, 75, 60, 50. |
| Sinus arrhythmia | Normal, physiologic. Irregular with a pattern: faster on inspiration, slower on expiration; 60–100, P before every narrow QRS. No treatment. |
| Sinus bradycardia: who | Regular, under 60. Adaptive in well-conditioned athletes, sleep, adults over 65. Causes: beta blockers, nondihydropyridine calcium channel blockers, digoxin, hypothyroidism, sinoatrial node ischemia, raised intracranial pressure, late infection. Most asymptomatic. |
| ★ Sinus bradycardia: treat | Asymptomatic: nothing (9:18). Acute, symptomatic, unstable: atropine first line (10:22), then temporary pacemaker. Chronic symptomatic: permanent pacemaker. |
| Sinus tachycardia | Regular, above 100 up to 160. Physiologic (pain, anxiety, exercise); pathologic (hypovolemia, shock, anemia, hypoxia, pulmonary embolism, infarction, hyperthyroidism); stimulants, anticholinergics; abrupt beta blocker withdrawal. Physiologic: usually no dizziness or nausea. |
| ★ Sinus tachycardia: treat | Appropriate: treat the underlying cause. Inappropriate = unexplained after causes excluded (diagnosis of exclusion, 20:20): remove triggers; beta blockers poorly tolerated (23:07); generally left untreated, prognosis usually benign. |
| ★ Sick sinus: forms | Irregular, variable rate (slow to fast up to 160). Exit block: impulse made, cannot leave the node. Sinus arrest: not made, leading to a junctional rhythm. Tachy-brady: fast rhythm (most commonly atrial fibrillation; 31:09) alternating with bradycardia or offset pauses. |
| Sick sinus: causes | Sinoatrial node ischemia, injury from cardiac surgery, electrolytes, hypothyroidism, beta blockers, nondihydropyridine calcium channel blockers, digoxin. |
| ★ Sick sinus: treat | Treat the cause (stop the drug). Symptoms do not correlate with bradycardia: observe. Symptomatic bradycardia: permanent pacemaker. Tachy-brady often needs one; with ventricular tachycardia: pacemaker with an implantable defibrillator (33:23). |
| Term | What you need to know |
|---|---|
| Umbrella | Any tachydysrhythmia above the bundle of His: sinus tachycardia, focal and multifocal atrial tachycardia, nodal and accessory pathway reentry, flutter, fibrillation. Narrow QRS by definition. Ventricular tachycardia is outside it. |
| Strip | Regular, above 160, P waves and PR hidden, QRS under 0.12 (except antidromic reentry). Irregular ones: atrial fibrillation (irregularly irregular), variable flutter, multifocal atrial tachycardia. |
| Symptoms | Palpitations, lightheadedness, fatigue, dyspnea, chest discomfort, nausea; worse in the elderly and structural heart disease. Syncope or collapse unusual unless above 200 (reentry, pre-excited atrial fibrillation). |
| ★ Stable | Vagal maneuver first, then adenosine (up to twice): may convert, or slow it to show hidden P waves (38:44–38:54). |
| ★ Unstable | Immediate synchronized cardioversion = timed shock at decreased voltage (not defibrillation) (40:44, 44:12). |
| Focal atrial | One ectopic atrial focus outside the sinus node: regular, one abnormal P shape. No heart disease, raised metabolic demand; abrupt-onset palpitations; benign. |
| Focal atrial: treat | Adenosine is diagnostic (rarely ends it). Unstable: synchronized cardioversion; amiodarone may be tried. Stable symptomatic: intravenous beta or nondihydropyridine calcium channel blocker. Chronic: oral; catheter ablation usually curative (90%). |
| ★ Multifocal atrial | At least 3 P shapes in one lead, irregular. Severe chronic obstructive pulmonary disease or heart failure, acutely ill. Poor prognostic sign: the one that turns unstable first (56:33). Treat the underlying condition. |
| Term | What you need to know |
|---|---|
| ★ Pre-excitation | Seen only in sinus rhythm (1:10:18): short PR (under 0.12) + delta wave (slurred QRS upstroke), widened QRS = accessory pathway (bundle of Kent) and potential for reentry. |
| Orthodromic vs antidromic | Orthodromic (more common): down the node, up the pathway: narrow, no delta wave, retrograde P after the QRS. Antidromic: down the pathway: wide, with a delta wave. Usually 200–300. Presents with palpitations. |
| ★ Accessory pathway: treat | Orthodromic: adenosine first line. Adenosine reveals atrial fibrillation with Wolff-Parkinson-White: intravenous procainamide, never adenosine (1:13:06). Chronic: catheter ablation of the pathway first line (1:14:47). |
| ★ Pre-excited atrial fibrillation | Irregular, wide, some rates approaching 300 (ventricular tachycardia: regular, 150–200). The most dangerous rhythm in Wolff-Parkinson-White, “the worst combination” (1:35:50). Procainamide; never adenosine (blocking the node leaves the pathway unopposed). |
| ★ Nodal reentry: who | Circuit within the atrioventricular node; slow-fast (typical) most common; usually 140–180, P hidden. Women >> men (1:18:09), no heart disease; exertion, caffeine, alcohol, beta-agonists, sympathomimetics. Sudden palpitations, neck pulsations (frog sign) (1:18:17). |
| ★ Nodal reentry: treat | Almost always ends with vagal maneuvers or adenosine (1:18:40); cardioversion rarely. Educated patient who ends it at home: no urgent care needed. Pill in the pocket (beta or nondihydropyridine calcium channel blocker). Ablation: cure over 95%. |
| Slide vs truth | Slide 37: known Wolff-Parkinson-White → procainamide, never adenosine. Guideline: adenosine is fine for regular orthodromic reentry; all nodal blockers are contraindicated in pre-excited atrial fibrillation. The course may key the slide. |
| Term | What you need to know |
|---|---|
| Flutter strip | Sawtooth waves, atrial rate 250 or more (approaching 300), more flutter waves than QRS; 2:1 block most common. |
| Flutter: who | Atrial scarring (after surgery), right-sided heart failure, pulmonary vascular disease, atrial fibrillation on an antiarrhythmic. Usually not life-threatening, but 1:1 flutter = extreme instability, risk of ventricular fibrillation. |
| Flutter: treat | Unstable: synchronized cardioversion. Stable: beta or calcium channel blocker; rate control harder than in fibrillation; substantial recurrence. Anticoagulate; cardioversion after 21 days; ablation definitive. |
| Fibrillation strip | Irregularly irregular, no P waves, usually 110–160. Paroxysmal under 1 week, ends alone; persistent over 7 days to 1 year; long-standing over 1 year; permanent = joint decision to stop rhythm attempts. |
| Fibrillation: who | Hypertension, diabetes, cardiac disease, family history, obesity, sleep apnea, alcohol, older age. Emergency: severe heart failure (pulmonary edema, hypotension) or an acute infarction. |
| ★ Fibrillation: treat | Unstable: synchronized cardioversion. Stable in rapid ventricular response: intravenous rate control; without it: oral rate control. Rate control first: goal number one (1:30:24). Cardioversion after 21 days of anticoagulation; mapping and ablation. |
| ★ Stroke vs bleeding | Anticoagulation prevents stroke from a clot. CHA2DS2-VASc (stroke risk): 0 in a man or 1 in a woman = low risk, may not need it. HAS-BLED estimates major bleeding on anticoagulation. Know what each score means, not its parts (1:33:24). |
| Drugs | Direct oral anticoagulants preferred in nonvalvular atrial fibrillation (dabigatran, apixaban, edoxaban, rivaroxaban). Warfarin: international normalized ratio 2–3. |
| Slide vs truth | Slide 50: “HAS-BLED 3 and up, no anticoagulation”. Truth: a high score flags bleeding risk to address and review, not to withhold. Slide 49 “anticoagulation for all” vs slide 50's low-risk line: learn slide 50. |
| Term | What you need to know |
|---|---|
| By origin | Atrial: early, abnormal P wave. Junctional: early narrow QRS, P inverted, buried or after the QRS. Ventricular: early, wide, bizarre QRS, no P (Lecture 30). Every other beat = bigeminy; every third = trigeminy. |
| Atrial premature: who | Chronic obstructive pulmonary disease; normal hearts with alcohol, stress, caffeine. In heart disease may precede supraventricular tachycardia, fibrillation or flutter. Most asymptomatic. |
| ★ Atrial premature: treat | Asymptomatic: none (1:39:07). Frequent: look for structural heart disease. Avoid triggers, reassure. Persistent symptomatic: beta blocker (metoprolol); ablation if frequent or triggering atrial fibrillation. |
| Junctional premature | P inverted in II, III, aVF: top of node = short PR, middle = buried, bottom = after the QRS (which origin gives which position is not examined, 1:40:13). Most not symptomatic. Over 10 per minute or multifocal: look for structural heart disease, beta blocker. Infrequent: reassure; persistent symptoms: metoprolol. |
| Junctional rhythm | Regular, 40–60, narrow, P inverted / buried / after; generally well tolerated. (Syllabus: Lecture 30 objective; taught on this deck.) |
| Junctional: causes | Sinus node dysfunction (sick sinus syndrome) or marked bradycardia, inferior infarction, after cardiac surgery, digoxin toxicity; healthy athletes with increased vagal tone. |
| ★ Junctional: treat | Healthy and asymptomatic: none (1:42:25). High-grade or complete block, or sick sinus syndrome: permanent pacemaker (1:42:47). Digoxin toxicity: atropine and/or digoxin immune Fab. |
| Term | What you need to know |
|---|---|
| ★ Her rules | Know each drug and when it is used; doses need not be memorized (1:14:38). Learn the most common cause and what to do (1:47). Not asked: atropine and epinephrine for the blocks (16:06), the QT-prolonging drug list (1:11:38), the arrest algorithm picture (1:29:42). |
| ★ Mobitz II and complete block | Emergently transcutaneous pacing, then a permanent pacemaker (16:15). Syncope in complete block = a really bad prognosis (23:28). |
| ★ Premature ventricular contractions | Her top point of the day: the main causes are hypoxemia and electrolyte imbalances, so check oxygen and electrolytes (52:50). Burden > 15% is high (53:20). |
| ★ Ventricular tachycardia: shock or not | Sustained = 30 s only if stable; unstable counts however short (1:05:19). Unstable with a pulse → synchronized cardioversion; no pulse → defibrillate (1:18:23). Polymorphic: defibrillate even with a pulse, then urgent coronary angiography (1:19:33). |
| ★ Torsades de pointes | Magnesium, then more magnesium (1:19:59). Amiodarone and procainamide prolong the QT; intravenous lidocaine does not (1:20:29). |
| ★ Arrest rhythms | No fibrillation with a pulse (1:21:59); defibrillate as soon as possible (1:26:37). Shockable: only ventricular fibrillation and pulseless ventricular tachycardia (59:00). Pulseless electrical activity: an organized rhythm with no pulse, so find why (1:31:47); hypovolemia and hypoxia (1:33:45). |
| Term | What you need to know |
|---|---|
| ★ First degree | PR > 0.20 s, constant, every P conducted, narrow QRS. Mostly asymptomatic; symptoms usually once PR > 0.3 s. Most common cause: age-related degeneration (2:06); vagal tone; beta blockers, non-dihydropyridine calcium channel blockers, digoxin; hypokalemia; nodal ischemia; hypertension; Lyme. No treatment; pacemaker only if symptomatic. |
| Mobitz I (Wenckebach) | PR lengthens until a QRS drops, then repeats; narrow QRS. Usually asymptomatic (dizziness, fatigue, exertional intolerance, syncope if not). Causes: vagal tone, nodal blocking drugs, Lyme carditis, nodal ischemia, cardiac ablation. No treatment; pacemaker if symptomatic. |
| Mobitz II | Constant PR, random dropped QRS; narrow QRS. Most common cause: acquired His-Purkinje disease (old age, hypertension, diabetes); Lyme; myocarditis, reactive arthritis; infarction; ablation. |
| Why Mobitz II is dangerous | Starts at the bundle of His → weak, unreliable escape rhythm; higher risk of complete heart block and sudden cardiac death; dangerous even without symptoms (unpredictable progression). Stokes-Adams attack = sudden faint or seizure from a rapid drop in brain blood flow. |
| Complete block | No P conducted: two unrelated regular rates, ventricular rate usually < 40; P waves may hide in the QRS, ST or T; PR random; QRS narrow or wide. |
| ★ Complete block: who and how bad | Symptoms set by the escape rate, escape site and underlying heart disease. Syncope = higher sudden-death risk. (23:28) Causes: acquired conduction disease (most common), Lyme, Chagas, endocarditis with abscess, myocarditis, amyloidosis, sarcoidosis, infarction, ablation. |
| ★ Treat Mobitz II and complete block | Transcutaneous pacing emergently → permanent pacemaker (definitive), even for asymptomatic Mobitz II. (16:15) |
| ★ Tell them apart | Does the PR lengthen before the drop? Yes = Mobitz I; no = Mobitz II. (16:46) No drops = first degree; no P conducted = complete. Lyme carditis causes all of them. |
| Term | What you need to know |
|---|---|
| Width | Complete bundle branch block = QRS 0.12 s or more (slide 21’s 0.20 is wrong). Left bundle splits into anterior and posterior fascicles. |
| Left: what | Left ventricle activated across the septum from the right. Dominant S in V1 (rS); R peak > 0.06; monophasic R laterally; no Q in I, V5, V6. |
| Left: causes | Chronic hypertension; ischemic heart disease, severe coronary disease; dilated non-ischemic cardiomyopathy; aortic stenosis; Lenègre–Lev disease (degenerative fibrosis). |
| ★ Left: symptoms, outlook | Usually none; symptoms = severe underlying heart disease, like a heart failure flare. (32:56) Prognosis follows the underlying disease. |
| ★ Left: treat | Usually untreated; symptomatic with reduced ejection fraction → biventricular pacemaker. New block = sign of pathology: evaluate. (33:52) |
| Right: what | Septum depolarizes normally via the left bundle; right ventricle late. rsR' (bunny ears) in V1–V3; slurred S in I and aVL. |
| Right: causes | Age-related degeneration; ischemic heart disease; pulmonary hypertension; pulmonary embolism (sudden right pressure rise); cardiomyopathies; myocarditis, amyloidosis. |
| ★ Right: outlook | Usually none; symptoms = severe heart disease. Treat the underlying condition. A new right block is not always pathological. (45:25) |
| Term | What you need to know |
|---|---|
| Look | Early, wide, bizarre QRS, no P wave. Bigeminy = every other beat; trigeminy = every third. |
| ★ Causes | Hypoxemia and electrolytes (low potassium, low magnesium, high calcium) first; (52:25) alcohol, caffeine, stimulants. With or without heart disease. |
| Symptoms | Mostly none; palpitations felt in the neck. |
| ★ High risk | Burden > 15% (15,000/day), beat-induced cardiomyopathy, structural or conduction disease, prior syncope. (54:48) Isolated beat-induced cardiomyopathy with heart failure → catheter ablation; otherwise beta blocker + optimize the heart disease. |
| Low risk | Symptoms: beta blocker first-line, ablation if refractory or not tolerated. Burden < 1%, normal heart, no symptoms: reassure, remove triggers. |
| ★ Sudden cardiac death | Unexpected cardiac death within 1 hour of collapse. Rhythms: ventricular fibrillation, pulseless ventricular tachycardia, pulseless electrical activity, asystole. (57:19) Most common cause: coronary artery disease, even without a prior infarction. |
| Defibrillators | Implantable: detects fatal rhythms and shocks; newer ones also pace. Wearable vest (LifeVest) also exists. Needed by most after unstable ventricular tachycardia. |
| Term | What you need to know |
|---|---|
| ★ What | 3 or more consecutive ventricular beats; regular, 100–250, wide QRS. Non-sustained < 30 s; sustained ≥ 30 s or collapse. (1:05:19) Monomorphic = same shape; polymorphic = shape varies. |
| Why | Monomorphic: existing heart disease. Polymorphic, normal QT: acute myocardial ischemia. Polymorphic, long QT = torsades. |
| ★ Non-sustained | Symptomatic: beta blocker first (1:13:28), then ablation, then amiodarone, lidocaine or procainamide. Asymptomatic: treat the underlying disease. Not a defibrillator indication by itself. |
| Sustained, stable monomorphic | Monitor, access, 12-lead, oxygen, labs; intravenous lidocaine, amiodarone or procainamide. No procainamide with a long QT or heart failure. |
| ★ Unstable | Any of chest pain, altered mental status, shortness of breath, hypotension. Pulse → synchronized cardioversion; pulseless → defibrillation. (1:18:31) Then an implantable defibrillator. |
| ★ Polymorphic | Never truly stable: defibrillate even with a pulse (1:19:33) → urgent coronary angiography. |
| Torsades | Polymorphic, QRS twists around the baseline; long QT the key risk. Long QT is congenital or acquired (most): drugs, hypokalemia, hypocalcemia. |
| ★ Treat torsades | Intravenous magnesium push, then infusion. (1:19:59) No amiodarone or procainamide (prolong QT); no beta blockers (bradycardia lengthens QT). Lidocaine can be used. Unstable → defibrillate. |
| Term | What you need to know |
|---|---|
| Ventricular fibrillation | Uncoordinated activity only, no pulse, no perfusion; rate 0. Coarse or fine. |
| Shockable? | Shockable: ventricular fibrillation, pulseless ventricular tachycardia. Unshockable: asystole, pulseless electrical activity. |
| ★ Fibrillation sequence | Cardiopulmonary resuscitation (CPR), oxygen, pads → defibrillate as soon as possible (1:26:37) → CPR 2 min → epinephrine every 3–5 min → shock → airway, 1 breath every 6 s with continuous compressions → amiodarone → lidocaine if still refractory. |
| ★ Asystole vs pulseless electrical activity | Asystole: no rate, rhythm, P or QRS. (1:29:54) Pulseless electrical activity: an organized rhythm (even sinus) with no pulse. |
| Pulseless electrical activity: why | Two leading causes in adults: hypovolemia and hypoxia. |
| Treat asystole and pulseless electrical activity | Compressions immediately; intubate early; high-quality cardiopulmonary resuscitation + epinephrine are the mainstays. |
| ★ Outlook | Poor, usually end-of-life. (1:34:19) Best-prognosis arrest rhythms: ventricular tachycardia and fibrillation. |
| Term | What you need to know |
|---|---|
| ★ Her study rules | Doses are not examined: “just know the names” (59:07). Cross off “fourth line” on the drug table (58:09): anti-interleukin-1 therapy now comes earlier (slide 35). Tamponade: no pressor names or fluid rates, but stabilize until the drainage (1:46:07). |
| ★ Rub and pain | The friction rub is the “big uh-oh” (2:42): the patient leans forward and holds a breath, so a rub that persists is pericardial; a pleural rub stops (2:16). Pain: sharp, substernal, worse lying down, better leaning forward (32:29). |
| ★ Diagnose it clinically | Two of four criteria (34:27). ST elevation everywhere, depression in aVR (40:57); weeks in, the tracing may have normalized: “think about the timeline.” (43:42). Keep myocardial infarction on the differential (36:16); C-reactive protein steers therapy (37:54). |
| ★ Treat and counsel | Anti-inflammatory + colchicine; after a myocardial infarction: aspirin + colchicine (54:24). Heart rate under 100 (55:26); stomach protection (56:19); finish the course (1:03:47); breathless or lightheaded → emergency room, not a call to the office (1:04:47). Recurrence 15–30%, “almost a third” (12:48). |
| ★ Effusion and tamponade | Fast fluid needs less volume to compress the heart (1:26:54); confirm with an echocardiogram (1:31:07); send the fluid for everything (31:23). Tamponade is an emergency (1:46:03), a clinical diagnosis confirmed when drainage makes the patient better (1:34:11). Older adult with an effusion: suspect malignancy (1:07:42). |
| ★ Recording vs slide | She called alternans, pulsus paradoxus and the Kussmaul sign “the triad” (1:16:02): wrong. Beck triad = hypotension, distended neck veins, muffled heart sounds (slide 54). Kussmaul sign = constriction; pulsus paradoxus = tamponade. Acute = under 4–6 weeks (slide 5; she said four). Radiation constriction can come years later. |
| Term | What you need to know |
|---|---|
| Three ways it presents | Acute or recurrent pericarditis; an effusion without major hemodynamic compromise; a compressive syndrome (tamponade, constrictive or effusive-constrictive pericarditis). Acute pericarditis is the most common disorder of the pericardium. |
| Time frames | Acute = less than 4–6 weeks. Incessant = more than 4–6 weeks, up to 3 months, no sustained remission. Recurrent = symptoms return after a symptom-free interval of 4–6 weeks or longer. Chronic = more than 3 months. |
| Compressive definitions | Tamponade = pericardial fluid under pressure compressing the heart. Constrictive = fibrous scarring and loss of elasticity. Effusive-constrictive = constriction that persists after the effusion is drained. |
| ★ How common | Acute pericarditis about 27.7 per 100,000 a year; about 5% of emergency admissions for nonischemic chest pain. Recurrence 15–30%. Effusion in up to 6.5% of adults (Framingham). Tamponade about 0.05% of admissions. Constriction uncommon after viral pericarditis. (12:36) |
| ★ Most common cause | Idiopathic, most likely viral: coxsackievirus and echovirus (grouped under children, though coxsackievirus is common in adults too); cytomegalovirus and human immunodeficiency virus in adults; often after an upper respiratory infection. (14:56) |
| ★ Other causes | Malignancy (especially effusion and tamponade); myocardial infarction or cardiac surgery (Dressler syndrome); chest radiation; autoimmune disease (lupus, rheumatoid arthritis); uremia (blood urea nitrogen above 60 mg/dL); tuberculosis (developing countries); drug-induced lupus from procainamide and hydralazine. (20:26) |
| Organisms | Bacterial: Staphylococcus, Pneumococcus, Streptococcus (rheumatic pancarditis), Haemophilus, Mycoplasma, tuberculosis. Fungal: Histoplasma, Aspergillus, Blastomyces, Coccidioides, Candida. Parasitic: Echinococcus, amebic, Toxoplasma. |
| Geography | Western Europe: idiopathic 55%, tuberculosis under 1%. Africa: idiopathic 13.7%, tuberculosis about 69.5%. |
| Treat the cause | Uremic → dialysis; autoimmune → steroids; tamponade → pericardiocentesis; usual inflammation → anti-inflammatory plus colchicine. |
| Older adults | Nonsteroidal anti-inflammatory drugs are on the Beers list; colchicine: consider a dose reduction; corticosteroids raise osteoporosis risk; higher suspicion for malignancy with an effusion or tamponade; higher surgical morbidity and mortality; often need rehabilitation; consults: cardiology and cardiothoracic surgery. |
| Term | What you need to know |
|---|---|
| ★ Pain | Sharp, pleuritic substernal pain, worse supine and on inspiration, relieved by leaning forward; may have fever. (32:29) |
| ★ Diagnosis | Clinical: two of four — sharp substernal chest pain; pericardial friction rub; widespread ST elevation; new or worsening effusion. Troponin is not a criterion. (34:27) |
| ★ Friction rub | Highly specific; triphasic, scratchy or squeaking; left sternal border, diaphragm; louder leaning forward and holding the breath. A pleural rub stops when the breath is held; the pericardial rub persists. (2:16) |
| ★ Electrocardiogram | Widespread concave ST elevation and PR depression; reciprocal ST depression and PR elevation in aVR; sinus tachycardia common. Stages: (1) ST up, PR down → (2) ST normalizes, T flattens → (3) T waves invert → (4) normal. (40:57) |
| Workup | Electrocardiogram, chest radiograph (typically normal), complete blood count, troponins, sedimentation rate, C-reactive protein, transthoracic echocardiogram (often normal unless an effusion). Raised troponin = myopericarditis. |
| High risk: admit | Fever above 38 °C; subacute course; tamponade signs; moderate-large effusion; immunosuppressed; oral anticoagulants; acute trauma; no improvement after 7 days; raised troponin. |
| ★ Treatment | Nonsteroidal anti-inflammatory drug (aspirin, ibuprofen or indomethacin) plus colchicine; colchicine 3 months (first episode); gastrointestinal protection. Prednisone if anti-inflammatories cannot be taken. Doses not examined. (56:19) |
| ★ After a heart attack | Aspirin plus colchicine; avoid other nonsteroidal anti-inflammatory drugs and glucocorticoids. (54:24) |
| ★ Activity & taper | No strenuous activity for at least 1 month, heart rate under 100, until symptoms and C-reactive protein settle. Taper when symptom-free 24 hours, or when C-reactive protein (checked weekly) normalizes. (55:26) |
| Failure | No response within 1 week → suspect a cause other than idiopathic or viral: persistent fever, pleuritic pain, a new effusion, worsening illness. Poorest prognosis in about 15% with high-risk features. |
| ★ Counseling | Head of bed elevated; finish the full course; activity limits; red flags (breathlessness, lightheadedness) → emergency department; refer to cardiology for no response, recurrence or constriction. (1:03:47) |
| ★ Recurrent | Colchicine 6 months or more. Inflammatory phenotype (C-reactive protein above 10 mg/L, fever, imaging inflammation): anakinra or rilonacept preferred, now used earlier; prednisone for systemic autoimmune disease. Multiple recurrences: high C-reactive protein, late gadolinium enhancement, autoimmune cause. (58:33) |
| Term | What you need to know |
|---|---|
| What | Scarred, inelastic pericardium limits filling: fluid overload (edema, anasarca) and low output (fatigue, exertional dyspnea). |
| Causes | More than 50% idiopathic or viral; cardiac surgery; prior radiation; infection (tuberculosis); connective tissue disease; uremia. |
| Examination | Elevated jugular venous pressure that rises on inspiration (Kussmaul sign); pericardial knock slightly earlier than a third heart sound (pathognomonic, rare); ascites, pulsatile hepatomegaly, cachexia when severe. |
| Mimics | Restrictive cardiomyopathy; cirrhosis; subacute tamponade. |
| Tests | Echocardiogram: thick pericardium, septal bounce, respiratory variation, biatrial enlargement. Electrocardiogram: nonspecific changes, low voltage, atrial fibrillation when advanced. Natriuretic peptide likely lower than in restrictive cardiomyopathy. |
| ★ Calcification | Highly specific, but most patients have none on chest radiograph — its absence does not exclude constriction. (1:20:10) |
| Confirm | Cardiac magnetic resonance or computed tomography for thickness; right heart catheterization with coronary angiography occasionally needed. |
| ★ Treatment | Often a surgical disease: pericardiectomy; diuretics used sparingly before surgery. Early stable disease: 2–3-month trial of anti-inflammatories, colchicine and diuretics. Treat tuberculosis to cut progression. (1:21:31) |
| ★ Prognosis | Low survival untreated. After pericardiectomy: 5-year nearly 80%, 10-year nearly 60%. Prior radiation = worst survival; older age, renal dysfunction, hyponatremia worsen it. (1:23:20) |
| Term | What you need to know |
|---|---|
| Symptoms | Small: none or vague (dull ache, fatigue, dyspnea). Large: dysphagia, nausea, hiccups, cough, hoarseness (recurrent laryngeal nerve). |
| ★ Speed matters | Acute: tamponade with under 200 mL. Chronic: large volume without tamponade, the pericardium stretches. (1:26:54) |
| Causes | Idiopathic; malignancy; infection (human immunodeficiency virus, Lyme disease, coxsackievirus, tuberculosis); after infarction or surgery; uremia, hypothyroidism (myxedema); lupus; trauma; doxorubicin, minoxidil, phenytoin, hydralazine, procainamide. |
| ★ Confirm | Echocardiogram is required to confirm; the heart may “swing” in a large effusion. (1:31:07) |
| Find the cause | Complete blood count, chemistry, thyroid-stimulating hormone, troponins; antinuclear antibody in a young woman; Lyme and human immunodeficiency virus serology; tuberculin skin test; albumin and urine protein; breast or lung cancer evaluation. |
| ★ Pericardiocentesis | Diagnostic when drained for tamponade, suspected neoplastic, purulent or tuberculous disease, or a moderate-to-large effusion of unknown cause. Fluid: acid-fast stain and mycobacterial culture (tuberculosis), cytology (malignancy), Gram stain and cultures; cell count rarely helpful. (31:23) |
| Window or pericardiectomy | Recurrent effusions and loculated, posterior effusions. |
| Prognosis & follow-up | Depends on the cause. Symptomatic malignant effusion: median 2–4 months → palliative care. Large effusions: serial transthoracic echocardiograms. Follow-up by cause: cardiology, infectious disease, nephrology, oncology, rheumatology. |
| Term | What you need to know |
|---|---|
| What | Fluid under pressure compresses the heart and impairs filling. Causes: acute pericarditis, iatrogenic injury, penetrating trauma, free-wall rupture after infarction, malignancy, aortic dissection. |
| ★ Beck triad | Muffled heart sounds, distended jugular veins, hypotension (slide 54). (1:27:43) |
| Pulsus paradoxus | Blood pressure drops 10 mmHg with inspiration; present in acute and subacute tamponade. |
| Tachycardia | Sinus tachycardia may mean significant compromise: immediate pericardiocentesis. |
| Electrocardiogram | Low-voltage QRS, tachycardia, electrical alternans (QRS height alternates beat to beat; fairly specific). |
| Imaging | Echocardiogram: right ventricular diastolic collapse. Chest radiograph: water-bottle heart, clear lungs. Catheterization: equal pressures in all chambers. Venous wave: prominent x, absent y descent. |
| ★ Diagnosis | Clinical; confirmed only by the response to drainage. (1:34:11) |
| Mimics | Acute: right ventricular infarction, aortic dissection, massive pulmonary embolism. Subacute: constrictive pericarditis, heart failure, cirrhosis. |
| ★ Treatment | Expedient pericardiocentesis = definitive. Intravenous fluid to raise preload until then; avoid diuretics. Hemorrhagic tamponade from trauma: emergent surgery. Signs in an office → emergency department. (1:44:08) |
| ★ Prognosis | Short term often good with prompt treatment; long term depends on the cause. (1:47:14) |
| Term | What you need to know |
|---|---|
| ★ Her study instructions | Prophylaxis: “you do need to know this is the prophylaxis stuff” (1:37). Doses: “Don’t memorize doses” (1:23:28), and again for children (1:41:55). Duke: the modified criteria as they stand now, not their history (48:13). Times are recording timestamps. |
| ★ Think staph first | Big three = staphylococci, enterococci, viridans streptococci (44:48), the groups empiric therapy covers. “Hence why your brain needs to think staph.” (40:46) Why vancomycin is in every empiric regimen: “we’re pretending it’s MRSA [methicillin-resistant Staphylococcus aureus] until somebody tells us it’s not MRSA” (1:15:54). |
| ★ Cultures, then kill it dead | “You need blood cultures on these patients, preferably before antibiotics” (1:00:19) Bactericidal (“kill it dead” 1:03:42); “the clock starts when you get your first negative culture” (1:04:17). Suspected endocarditis is a hospital problem (1:07:50). |
| ★ One painful, one not | “One of them is painful one is not” (29:14) Osler = painful (her aid: “Osler’s painful pustules”, 29:53); Janeway = painless. Injection drug use → tricuspid valve; cough is the symptom linked to it (26:23). |
| ★ Consults and the no | Infectious disease for every patient (1:08:22); addiction medicine with injection drug use (1:12:57). Anticoagulation: “Do we anticoagulate them? No.” (1:27:52) |
| ★ Recording vs slide | She said empiric “vancomycin, rifampin, and gentamicin” (1:22:17): that is the prosthetic valve Staphylococcus aureus regimen; learn slide 27’s empiric pairs. “IM [intramuscular] injection of amoxicillin” (1:33:11): learn ampicillin. Bronchoscopy: she would cover it; learn the slide (only with a biopsy). |
| Term | What you need to know |
|---|---|
| What | Invasion and colonization of the endocardium by microorganisms → inflammation and a vegetation: platelets, fibrin, micro-colonies of organisms, inflammatory cells. Heart valves = most common site; also the low-pressure side of a ventricular septal defect, endocardium hit by jets or foreign bodies, intracardiac devices. |
| Types | Native valve; prosthetic valve; implantable electronic device (pacemaker, defibrillator); health care-associated: hospitalized patient with fever and positive cultures without an apparent source. Classified by tempo, site, cause (organism) and predisposing risk factor. |
| Who | Over 60 = more than 50% of cases; men more than women; injection drug use, immunocompromise, human immunodeficiency virus, poor dentition; congenital, rheumatic and degenerative valve disease; devices; prosthetic valves. |
| ★ Settings | Native valve: 25–35% health care-associated. Prosthetic valves 16–35% of cases, greatest risk in the first year. Device infection within weeks of implantation or generator change. High-income countries: degenerative valve disease and devices lead. (17:43) |
| ★ Acute | Hectically febrile, 3–10 days, high fevers, systemic toxicity; virulent organism (Staphylococcus aureus, beta-hemolytic streptococci); rapidly damages the heart, seeds extracardiac sites; untreated = death within weeks. (21:32) |
| Subacute | Indolent: lower fevers, malaise, weight loss over weeks to months; viridans streptococci, enterococci, coagulase-negative staphylococci, HACEK (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella); rarely metastasizes; progressive unless a major embolus or ruptured mycotic aneurysm. |
| Term | What you need to know |
|---|---|
| ★ Symptoms | Fever = most common; chills, sweats, myalgias, headache, anorexia, weight loss, malaise, neurologic deficits. Cough is linked to people who inject drugs; the lung is on the embolic map (spleen, lung, kidney, liver). (26:23) |
| ★ Osler vs Janeway | Osler nodes: PAINFUL, finger and toe pads, crops that fade in 2–3 days, immunologic. Janeway lesions: PAINLESS flat hemorrhagic macules, palms and soles, vascular (embolic), associated with acute endocarditis. (29:14) |
| Other stigmata | Roth spots: white-centered retinal hemorrhages (small-artery vasculitis). Splinter hemorrhages: under finger and toenails (embolic). Petechiae: palate (buccal mucosa), conjunctiva, extremities. |
| Cardiac | New murmur = valve damage or chordae tendineae rupture → regurgitation. Heart failure = valvular dysfunction. Perivalvular abscess beyond the leaflets: into the epicardium → pericarditis; into the upper septum → conduction block. |
| Source → organism | Mouth → viridans streptococci. Skin → staphylococci. Upper respiratory → HACEK (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella) (gram-negative; Eikenella corrodens). Gut → Streptococcus gallolyticus. Genitourinary → enterococci. Fungal → Candida. |
| ★ Setting → organism | Early prosthetic: coagulase-negative staphylococci + Staphylococcus aureus; late prosthetic: viridans streptococci. Injection drug use: Staphylococcus aureus (> 60%; 80–90% of tricuspid). Health care-associated native valve: Staphylococcus aureus about 52%. Device: coagulase-negative staphylococci about 41%. (40:46) |
| Mimics | Lupus (Libman-Sacks, non-infective); antiphospholipid syndrome (thromboemboli + valve disease); polymyalgia rheumatica (myalgia, high inflammatory markers); vasculitis; reactive arthritis; Lyme; meningitis; tuberculosis; atrial myxoma (fever, new murmur, tumor plop). |
| Term | What you need to know |
|---|---|
| Major 1: cultures | Typical organism in two separate cultures (viridans streptococci, Streptococcus gallolyticus, HACEK (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella), Staphylococcus aureus, community enterococci without a focus) or persistently positive (> 12 hours apart; all 3 or most of 4+, first and last ≥ 1 hour apart). |
| Major 2: endocardium | Echo: oscillating intracardiac mass, abscess, or new partial dehiscence of a prosthetic valve; or new valvular regurgitation. A louder or changed old murmur is not sufficient. |
| Minor (5) | Predisposition (heart condition or injection drug use); fever ≥ 38.0 °C; vascular (emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctival hemorrhages, Janeway); immunologic (glomerulonephritis, Osler, Roth, rheumatoid factor); microbiologic. |
| Contaminants | A single culture of coagulase-negative staphylococci or diphtheroids is excluded (common contaminant). |
| ★ Verdict | Definite: 2 major / 1 major + 3 minor / 5 minor. Possible: 1 major + 1 minor / 3 minor. (55:17, 57:18) |
| ★ Cultures | 3 sets from separate sites within 24 hours; acute picture: two within the first 1–2 hours. Always before antibiotics. (1:00:17) |
| ★ Echo | Transesophageal: highly sensitive and specific, defines the extent, shows leaflet vegetations. A normal one does not rule endocarditis out. (1:01:54) |
| Labs | Complete blood count: leukocytosis, anemia of chronic disease (normal mean corpuscular volume). Urinalysis: hematuria, proteinuria, pyuria. |
| Term | What you need to know |
|---|---|
| ★ Principles | Kill every organism in the vegetation: bactericidal, prolonged (4–6 weeks from the first NEGATIVE culture), parenteral; admit, monitor labs, renal function and the heart; empiric therapy ONLY after cultures. (1:04:17) |
| ★ Empiric | Covers staphylococci, streptococci, enterococci. Native valve, subacute, or prosthetic valve > 1 year: vancomycin + ceftriaxone. Prosthetic valve ≤ 1 year: vancomycin + gentamicin + cefepime. (1:15:54) |
| ★ Staphylococcus aureus | Methicillin-susceptible: nafcillin or oxacillin; cefazolin. Methicillin-resistant: vancomycin or daptomycin. Prosthetic valve: add rifampin + gentamicin. (1:25:15) |
| Others | Viridans streptococci: penicillin G or ceftriaxone (± gentamicin) or vancomycin; 2-week gentamicin regimen only if uncomplicated, rapid response, no chronic kidney disease. Enterococci: ampicillin + gentamicin. HACEK (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella): ceftriaxone. |
| Other streptococci | Streptococcus gallolyticus (bovis): associated with liver disease or cirrhosis and gastrointestinal abnormalities, especially colon cancer. Listed regimens: penicillin; cefazolin; ceftriaxone; vancomycin + ceftriaxone + oral rifampin. (IE Missing Slide and Cases, slide 1) |
| Enterococci: options | (Penicillin or ampicillin) + gentamicin; ampicillin + ceftriaxone (good for chronic kidney disease or acute kidney injury with a low creatinine clearance). (IE Missing Slide and Cases, slide 1) |
| HACEK organisms | HACEK (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella): ceftriaxone or a third-generation cephalosporin; penicillin allergy: could consider fluoroquinolones. (IE Missing Slide and Cases, slide 1) |
| Culture-negative endocarditis | May be due to infection from organisms not recovered in routine microbiology testing, or to antimicrobials given before blood cultures were obtained. (IE Missing Slide and Cases, slide 1) |
| ★ Consults | Infectious disease: antibiotics and outpatient monitoring. Cardiothoracic surgery: surgery and anticoagulation needs. Addiction medicine: harm reduction. Rehabilitation? Palliative care? (1:08:22) |
| ★ Surgery | Heart failure from valve dysfunction (most common); infection not resolving on appropriate antibiotics; abscess; fungal (hard to cure with drugs alone). Anticoagulation: not beneficial for native valves, controversial for prosthetic. (1:27:17, 1:27:52) |
| ★ Prognosis | Staphylococcus aureus = most lethal (prosthetic valve about 50% > non-injecting about 30% > injection drug use about 5%). Viridans streptococci: relatively good if treated before complications. Enterococci: resistance; valve replacement in 30–40%. Fungi: large peripheral artery emboli. (1:35:37) |
| Term | What you need to know |
|---|---|
| ★ Who | Prosthetic valves (incl. transcatheter, homografts) or valve-repair material; previous endocarditis; unrepaired cyanotic congenital heart disease; repaired disease with residual defects at prosthetic material; first 6 months after repair with prosthetic material or a device; transplant with valve regurgitation. (1:29:37) |
| ★ YES | Dental work that manipulates the gums or periapical region or perforates the mucosa (cleaning, root canal, extraction); respiratory procedures that incise or biopsy the mucosa (tonsillectomy, adenoidectomy). (1:30:16) |
| ★ NO | Anesthetic injections through clean tissue; dental radiographs; orthodontic appliances and brackets; bleeding from lip or mucosal trauma; bronchoscopy unless biopsy; cystoscopy, upper endoscopy, colonoscopy (no active infection). (1:31:23) |
| ★ Regimen | ONE dose, 30–60 minutes BEFORE. Standard: oral amoxicillin. No oral: ampicillin intramuscular or intravenous (or cefazolin, ceftriaxone). Allergic, oral: azithromycin or clarithromycin, doxycycline, cephalexin. Allergic, no oral: cefazolin or ceftriaxone. (1:32:41) |
| ★ Traps | Clindamycin dropped (Clostridioides difficile). No cephalosporin after anaphylaxis, angioedema or urticaria to penicillin. (1:33:58) |
| Infant | Driven by congenital heart disease and central lines. Sepsis-like: poor feeding, respiratory distress, tachycardia, hypotension, new murmur. Septic emboli → osteomyelitis, meningitis, pneumonia. Candida with lines, hyperalimentation, prematurity. |
| Child / adolescent | Child > 1 year with congenital disease: viridans streptococci, then Staphylococcus aureus; indolent; fulminant = pneumococcus or Staphylococcus aureus. Shunt: falling oxygen saturation, murmur unchanged. Adolescents resemble adults (injection drug use). |
| ★ Children vs adults | Low incidence, high mortality (5–16%); more right-sided, more emboli, less heart failure; fewer peripheral stigmata. Treat like adults: intravenous, prolonged, bactericidal, weight-based. (1:38:21) |
| Elderly | Over 60 = more than half of cases; plan rehabilitation for the deconditioned; palliative care where appropriate. |